(this.webpackJsonpweb=this.webpackJsonpweb||[]).push([[0],{108:function(e,t,a){e.exports=a.p+"static/media/logo.aa6b7ebb.svg"},125:function(e,t){function a(e){var t=new Error("Cannot find module '"+e+"'");throw t.code="MODULE_NOT_FOUND",t}a.keys=function(){return[]},a.resolve=a,e.exports=a,a.id=125},138:function(e,t,a){var i={"./SearchIcon":200,"./SearchIcon.js":200,"./approach/annotation.svg":710,"./approach/collecting.new.svg":711,"./approach/collecting.svg":712,"./approach/detailed_analysis.new.svg":713,"./approach/detailed_analysis.svg":714,"./approach/drugs-atc5-dendrogram-latest.png":715,"./approach/file_searching.svg":716,"./approach/file_system.svg":717,"./approach/files.svg":718,"./approach/kg.svg":719,"./approach/medical_research.new.svg":720,"./approach/medical_research.svg":721,"./approach/professor.new.svg":722,"./approach/professor.svg":723,"./approach/report.new.svg":724,"./approach/report.svg":725,"./approach/reviewed_docs.new.svg":726,"./approach/reviewed_docs.svg":727,"./approach/tools.svg":208,"./approach/undraw_annotation_7das.svg":728,"./approach/undraw_collecting_fjjl.svg":729,"./approach/undraw_detailed_analysis_xn7y.svg":730,"./approach/undraw_medical_research_qg4d.svg":731,"./approach/undraw_professor_8lrt.svg":732,"./approach/undraw_report_mx0a.svg":733,"./approach/undraw_reviewed_docs_neeb.svg":734,"./data/chartdata":29,"./data/chartdata.js":29,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0001.png":237,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0002.png":238,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0003.png":239,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0004.png":240,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0005.png":241,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0006.png":242,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0007.png":243,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0008.png":244,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0009.png":245,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0010.png":246,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0011.png":247,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0012.png":248,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0013.png":249,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0014.png":250,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0015.png":251,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0016.png":252,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0017.png":253,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0018.png":254,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0019.png":255,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0020.png":256,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0021.png":257,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0022.png":258,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0023.png":259,"./data/slides/Drugs4Covid-EUvsVirus.pptx_page-0024.png":260,"./logo.min.svg":218,"./logo.svg":108,"./logo.white.svg":735,"./logos/FacInformatica.jpg":736,"./logos/Logo_OEG.jpg":737,"./logos/image.png":738,"./logos/oeg.jpg":739,"./logos/upm.png":740,"./teamImages/Fotos/200.png":741,"./teamImages/Fotos/AlbaFernandez.png":742,"./teamImages/Fotos/AnaIglesiasMolina.jpg":743,"./teamImages/Fotos/BeatrizL\xf3pezCenteno.jpg":744,"./teamImages/Fotos/CarlosBadenesOlmedo.png":745,"./teamImages/Fotos/DanielBermejoS\xe1nchez.jpg":746,"./teamImages/Fotos/DavidChaves.jpg":747,"./teamImages/Fotos/EdnaRuckhaus.png":748,"./teamImages/Fotos/ElviraAmador.JPG":749,"./teamImages/Fotos/EstebanGonz\xe1lezGuardia.jpeg":750,"./teamImages/Fotos/Ignacio-IkerPrado-Rujas.jpg":751,"./teamImages/Fotos/JU_N.jpg":752,"./teamImages/Fotos/MariaPoveda.jpg":753,"./teamImages/Fotos/MaydadePabloLlorente.png":754,"./teamImages/Fotos/OscarCorcho.jpeg":755,"./teamImages/Fotos/PabloCallejaIba\xf1ez.jpg":756,"./teamImages/Fotos/PaolaEspinozaArias.jpg":757,"./teamImages/Fotos/PatriciaMart\xednChozas.png":758,"./teamImages/Fotos/SocorroBernardos.png":759,"./teamImages/Fotos/VirginiadePablo.png":760,"./teamImages/Fotos/asuncion.jpg":761,"./teamImages/Fotos/luisPozo.png":762,"./teamImages/yoHead.png":763};function n(e){var t=r(e);return a(t)}function r(e){if(!a.o(i,e)){var t=new Error("Cannot find module '"+e+"'");throw t.code="MODULE_NOT_FOUND",t}return i[e]}n.keys=function(){return Object.keys(i)},n.resolve=r,e.exports=n,n.id=138},200:function(e,t,a){"use strict";a.r(t);var i=a(1),n=a.n(i);t.default=function(){return n.a.createElement("svg",{xmlns:"http://www.w3.org/2000/svg",xmlnsXlink:"http://www.w3.org/1999/xlink",width:"28.25",height:"39.42",viewBox:"504.409 230.339 29.254 40.421"},n.a.createElement("defs",null,n.a.createElement("path",{d:"M505.41 231.34h20.45v20.47h-20.45v-20.47z"}),n.a.createElement("path",{id:"i1pBFCDxGk",d:"M517.44 236.81c-.17.35-.27.54-.29.58a3.39 3.39 0 00-1.26-.26c0-.05-.01-.26-.03-.65h.02c.16-.01.26-.14.26-.28a.278.278 0 00-.29-.26c-.06.01-.52.03-.58.04-.15 0-.27.13-.26.28.01.15.14.26.29.25h.02c.02.39.03.6.04.65-.44.05-.85.19-1.22.4-.03-.04-.15-.22-.36-.54.02-.01.02-.01.02-.02.13-.08.16-.24.08-.37a.272.272 0 00-.37-.08c-.05.03-.44.29-.49.32-.13.09-.16.25-.08.38.08.12.25.16.37.08 0-.01.01-.01.02-.02.22.33.33.51.36.54-.34.27-.63.59-.86.96-.04-.02-.23-.12-.58-.29.01-.01.01-.02.01-.02.07-.14.01-.3-.11-.36a.274.274 0 00-.37.11c-.02.06-.23.48-.26.53-.07.13-.01.29.12.36s.29.01.36-.12c0 0 0-.01.01-.02.35.17.54.27.58.29-.08.2-.15.4-.19.62-.05.21-.07.43-.08.64-.04 0-.25.01-.64.03v-.02a.27.27 0 00-.29-.25c-.14 0-.26.13-.25.28 0 .06.03.53.03.59.01.14.14.26.29.25a.27.27 0 00.25-.29v-.02c.39-.02.6-.03.64-.03.06.43.2.84.41 1.21-.04.03-.22.15-.55.36 0-.01-.01-.02-.01-.02a.264.264 0 00-.37-.08c-.13.08-.16.25-.08.37.03.05.29.45.32.49.08.13.25.16.37.08.13-.08.16-.25.08-.37 0 0 0-.01-.01-.02.32-.21.5-.33.54-.35.26.33.58.63.96.85-.02.04-.12.23-.29.58-.02-.01-.02-.01-.03-.01a.26.26 0 00-.36.12c-.07.13-.01.29.12.36.05.03.47.24.52.26.14.07.3.02.37-.12.06-.12.01-.29-.12-.36 0 0-.01 0-.02-.01.17-.34.27-.54.29-.57.19.08.4.14.61.19.22.04.43.06.64.07.01.04.02.26.04.64h-.02a.271.271 0 10.03.54c.05 0 .52-.03.58-.03.15-.01.26-.14.26-.29a.277.277 0 00-.29-.25h-.02c-.02-.38-.03-.6-.04-.64.43-.06.85-.2 1.22-.4.03.03.14.21.36.54l-.02.01c-.13.08-.16.25-.08.37.08.13.25.16.37.08.05-.03.44-.29.49-.32.13-.08.16-.25.08-.37a.264.264 0 00-.37-.08c-.01 0-.01.01-.02.01-.22-.32-.33-.5-.36-.54.34-.26.63-.58.86-.95.04.01.23.11.57.29 0 .01 0 .02-.01.02-.06.14 0 .29.12.36.14.07.3.01.37-.12.02-.05.23-.47.26-.52.07-.14.01-.3-.12-.36a.265.265 0 00-.36.11s-.01.01-.01.02c-.35-.17-.54-.27-.58-.28.08-.2.15-.41.19-.62.05-.22.07-.43.07-.64.05 0 .26-.02.65-.04v.03c.01.14.14.26.28.25.15-.01.27-.14.26-.28 0-.06-.03-.53-.03-.59a.27.27 0 00-.29-.25c-.14 0-.26.13-.25.28v.02c-.39.03-.6.04-.64.04-.06-.43-.2-.84-.41-1.22.04-.02.22-.14.54-.35.01.01.02.01.02.02.08.12.25.16.37.08.12-.09.16-.25.08-.38-.03-.05-.29-.44-.32-.49a.272.272 0 00-.37-.08c-.13.08-.17.25-.08.38l.01.01-.54.36c-.26-.34-.58-.63-.96-.86.02-.04.12-.23.29-.57.02 0 .02.01.02.01.14.07.3.01.37-.12.06-.13.01-.3-.12-.36-.05-.03-.47-.24-.53-.27-.13-.07-.29-.01-.36.12a.27.27 0 00.12.36s.01.01.02.01zm-4.52 3.21c.34-1.6 1.91-2.63 3.5-2.29 1.6.33 2.63 1.9 2.29 3.5a2.965 2.965 0 01-3.5 2.29 2.975 2.975 0 01-2.29-3.5z"}),n.a.createElement("path",{id:"aFIILHUTY",d:"M522.06 248.3l-1.52-.28-1.14.94 12.33 21.27 1.67-.45-11.34-21.48z"}),n.a.createElement("path",{id:"e1pUKJlHYS",d:"M522.06 248.3l-1.52-.28-1.14.94 12.33 21.27 1.67-.45-11.34-21.48z"}),n.a.createElement("path",{id:"bGuKiG5X",d:"M519.96 250.22l-2.05.93-.69 1.6.12 1.15 1.7-.13 1.54-1.75-.62-1.8z"}),n.a.createElement("path",{id:"bu63OR5lD",d:"M519.96 250.22l-2.05.93-.69 1.6.12 1.15 1.7-.13 1.54-1.75-.62-1.8z"}),n.a.createElement("path",{id:"cmO7MU26P",d:"M527.76 253.36l-.82 2.39-2.24 1.53-.37.72.16 1.4.97-.1 1.43 2.57-.66.16-.94.03-2.36-1.74-.52-2.67 1.65-1.92 1.74-1.51-.48-2.17-1.5-1.2-.95-1.62 2.05.4 2 1.32.84 2.41z"}),n.a.createElement("path",{id:"a7mce9hyTE",d:"M527.76 253.36l-.82 2.39-2.24 1.53-.37.72.16 1.4.97-.1 1.43 2.57-.66.16-.94.03-2.36-1.74-.52-2.67 1.65-1.92 1.74-1.51-.48-2.17-1.5-1.2-.95-1.62 2.05.4 2 1.32.84 2.41z"}),n.a.createElement("path",{id:"d5jweFtW6Q",d:"M531.54 264.74l-1.79.88-.18.88 1.4 2.3-.49.48-1.44-.72-1.29-2.24.69-1.4 1.73-1.76-.61-.7-1.17-2.56 2 .57 1.44 1.95-.29 2.32z"}),n.a.createElement("path",{id:"b1JeHIk2qX",d:"M531.54 264.74l-1.79.88-.18.88 1.4 2.3-.49.48-1.44-.72-1.29-2.24.69-1.4 1.73-1.76-.61-.7-1.17-2.56 2 .57 1.44 1.95-.29 2.32z"}),n.a.createElement("path",{id:"a4qCKY8Z4k",d:"M522.93 248.85l-.21-.41c-.01-.01-.02-.02-.02-.03-.49-.88-1.65-1.27-2.6-.89-.94.38-1.32 1.41-.83 2.28.01.01.01.03.02.04 0 0 .02.03.05.08-.72.29-1.11.45-1.19.49-.45.18-.78.51-.94.92-.07.16-.56 1.42-.62 1.58-.14.35-.08.74.16 1.06.35.49 1.02.71 1.61.53.03-.01.06-.03.1-.04l.18-.09c.16-.1 1.38-.84 1.53-.93.35-.21.59-.53.71-.89.2.35 1.83 3.11 2.03 3.46-1.03 1.09-1.28 2.71-.48 4.15.42.77 1.1 1.4 1.94 1.81.72.35 1.53.52 2.32.49l1.3 2.2c-.76.87-.93 2.11-.31 3.22.62 1.13 1.91 1.84 3.26 1.82.02.04.2.34.22.37.34.59 1.14.85 1.78.59.64-.26.91-.96.59-1.55-.2-.39-1.81-3.46-2.01-3.84.93-.94 1.16-2.37.46-3.62-.65-1.17-1.98-1.94-3.39-1.99-.34-.65-1.54-2.93-1.71-3.26 1.34-1.24 1.71-3.2.75-4.93-.9-1.61-2.75-2.64-4.7-2.62zm-4.91 4.89a.506.506 0 01-.54-.17.363.363 0 01-.05-.36c.06-.16.56-1.42.62-1.57.08-.23.27-.41.5-.5.08-.04.49-.2 1.21-.49.26.43.4.67.43.72a.37.37 0 00-.16.42c.11.38-.04.77-.39.98-.15.09-1.37.83-1.53.93-.03.02-.06.03-.09.04zm6.32-2.19c.48.35.78.64.92.89.23.41.29.85.21 1.26-.08-.14-.45-.86-1.13-2.15zm-2.08-2.14s.01 0 .01.01c.27.52 2.44 4.67 2.71 5.19a1.9 1.9 0 01-.69.46c-.26.11-.5.24-.73.39-.34-.6-3.14-5.36-3.49-5.96 0-.01-.01-.01-.01-.02-.26-.47-.06-1.02.45-1.23.51-.21 1.14.01 1.4.48 0 .01 0 .01.01.02.03.06.31.59.34.66zm3.96 12.25c-1.24-.08-2.42-.78-3-1.82-.86-1.55-.19-3.36 1.48-4.04 1.53-.62 2.13-2.27 1.35-3.68-.45-.81-1.28-1.4-2.24-1.6-.05-.08-.41-.77-.46-.86 1.46.1 2.81.91 3.49 2.14 1.01 1.81.23 3.93-1.74 4.73-1.23.51-1.72 1.84-1.09 2.99.11.2.38.29.6.2.18-.07.27-.24.23-.42l1.38 2.36zm2.42 2.45c-.37-.64-3.37-5.75-3.75-6.39.15-.19.36-.35.62-.46.24-.1.47-.21.68-.34.69 1.3 3.08 5.88 3.42 6.53a.87.87 0 01-.45.39c-.19.08-.36.17-.52.27zm1.36 2.31c.05-.17.18-.31.37-.39.17-.07.32-.14.47-.23.13.24.76 1.45 1.89 3.61.01.29-.05.46-.2.52-.21.09-.47 0-.59-.2-.19-.33-1.75-2.98-1.94-3.31zm.46 2.45c-.84-.11-1.59-.6-1.99-1.32-.63-1.14-.14-2.48 1.09-2.98.95-.38 1.32-1.41.84-2.28a.485.485 0 00-.55-.22c-.08-.16-.74-1.41-.82-1.57.91.15 1.73.7 2.16 1.47.71 1.28.16 2.77-1.22 3.33-.8.33-1.12 1.19-.71 1.93.08.14.22.22.37.24.08.14.74 1.26.83 1.4z"}),n.a.createElement("path",{id:"h1QMDcBePp",d:"M522.93 248.85l-.21-.41c-.01-.01-.02-.02-.02-.03-.49-.88-1.65-1.27-2.6-.89-.94.38-1.32 1.41-.83 2.28.01.01.01.03.02.04 0 0 .02.03.05.08-.72.29-1.11.45-1.19.49-.45.18-.78.51-.94.92-.07.16-.56 1.42-.62 1.58-.14.35-.08.74.16 1.06.35.49 1.02.71 1.61.53.03-.01.06-.03.1-.04l.18-.09c.16-.1 1.38-.84 1.53-.93.35-.21.59-.53.71-.89.2.35 1.83 3.11 2.03 3.46-1.03 1.09-1.28 2.71-.48 4.15.42.77 1.1 1.4 1.94 1.81.72.35 1.53.52 2.32.49l1.3 2.2c-.76.87-.93 2.11-.31 3.22.62 1.13 1.91 1.84 3.26 1.82.02.04.2.34.22.37.34.59 1.14.85 1.78.59.64-.26.91-.96.59-1.55-.2-.39-1.81-3.46-2.01-3.84.93-.94 1.16-2.37.46-3.62-.65-1.17-1.98-1.94-3.39-1.99-.34-.65-1.54-2.93-1.71-3.26 1.34-1.24 1.71-3.2.75-4.93-.9-1.61-2.75-2.64-4.7-2.62zm-4.91 4.89a.506.506 0 01-.54-.17.363.363 0 01-.05-.36c.06-.16.56-1.42.62-1.57.08-.23.27-.41.5-.5.08-.04.49-.2 1.21-.49.26.43.4.67.43.72a.37.37 0 00-.16.42c.11.38-.04.77-.39.98-.15.09-1.37.83-1.53.93-.03.02-.06.03-.09.04zm6.32-2.19c.48.35.78.64.92.89.23.41.29.85.21 1.26-.08-.14-.45-.86-1.13-2.15zm-2.08-2.14s.01 0 .01.01c.27.52 2.44 4.67 2.71 5.19a1.9 1.9 0 01-.69.46c-.26.11-.5.24-.73.39-.34-.6-3.14-5.36-3.49-5.96 0-.01-.01-.01-.01-.02-.26-.47-.06-1.02.45-1.23.51-.21 1.14.01 1.4.48 0 .01 0 .01.01.02.03.06.31.59.34.66zm3.96 12.25c-1.24-.08-2.42-.78-3-1.82-.86-1.55-.19-3.36 1.48-4.04 1.53-.62 2.13-2.27 1.35-3.68-.45-.81-1.28-1.4-2.24-1.6-.05-.08-.41-.77-.46-.86 1.46.1 2.81.91 3.49 2.14 1.01 1.81.23 3.93-1.74 4.73-1.23.51-1.72 1.84-1.09 2.99.11.2.38.29.6.2.18-.07.27-.24.23-.42l1.38 2.36zm2.42 2.45c-.37-.64-3.37-5.75-3.75-6.39.15-.19.36-.35.62-.46.24-.1.47-.21.68-.34.69 1.3 3.08 5.88 3.42 6.53a.87.87 0 01-.45.39c-.19.08-.36.17-.52.27zm1.36 2.31c.05-.17.18-.31.37-.39.17-.07.32-.14.47-.23.13.24.76 1.45 1.89 3.61.01.29-.05.46-.2.52-.21.09-.47 0-.59-.2-.19-.33-1.75-2.98-1.94-3.31zm.46 2.45c-.84-.11-1.59-.6-1.99-1.32-.63-1.14-.14-2.48 1.09-2.98.95-.38 1.32-1.41.84-2.28a.485.485 0 00-.55-.22c-.08-.16-.74-1.41-.82-1.57.91.15 1.73.7 2.16 1.47.71 1.28.16 2.77-1.22 3.33-.8.33-1.12 1.19-.71 1.93.08.14.22.22.37.24.08.14.74 1.26.83 1.4z"}),n.a.createElement("path",{id:"c2MCOs8wsy",d:"M522.93 248.85l-.21-.41c-.01-.01-.02-.02-.02-.03-.49-.88-1.65-1.27-2.6-.89-.94.38-1.32 1.41-.83 2.28.01.01.01.03.02.04 0 0 .02.03.05.08-.72.29-1.11.45-1.19.49-.45.18-.78.51-.94.92-.07.16-.56 1.42-.62 1.58-.14.35-.08.74.16 1.06.35.49 1.02.71 1.61.53.03-.01.06-.03.1-.04l.18-.09c.16-.1 1.38-.84 1.53-.93.35-.21.59-.53.71-.89.2.35 1.83 3.11 2.03 3.46-1.03 1.09-1.28 2.71-.48 4.15.42.77 1.1 1.4 1.94 1.81.72.35 1.53.52 2.32.49l1.3 2.2c-.76.87-.93 2.11-.31 3.22.62 1.13 1.91 1.84 3.26 1.82.02.04.2.34.22.37.34.59 1.14.85 1.78.59.64-.26.91-.96.59-1.55-.2-.39-1.81-3.46-2.01-3.84.93-.94 1.16-2.37.46-3.62-.65-1.17-1.98-1.94-3.39-1.99-.34-.65-1.54-2.93-1.71-3.26 1.34-1.24 1.71-3.2.75-4.93-.9-1.61-2.75-2.64-4.7-2.62zm-4.91 4.89a.506.506 0 01-.54-.17.363.363 0 01-.05-.36c.06-.16.56-1.42.62-1.57.08-.23.27-.41.5-.5.08-.04.49-.2 1.21-.49.26.43.4.67.43.72a.37.37 0 00-.16.42c.11.38-.04.77-.39.98-.15.09-1.37.83-1.53.93-.03.02-.06.03-.09.04zm6.32-2.19c.48.35.78.64.92.89.23.41.29.85.21 1.26-.08-.14-.45-.86-1.13-2.15zm-2.08-2.14s.01 0 .01.01c.27.52 2.44 4.67 2.71 5.19a1.9 1.9 0 01-.69.46c-.26.11-.5.24-.73.39-.34-.6-3.14-5.36-3.49-5.96 0-.01-.01-.01-.01-.02-.26-.47-.06-1.02.45-1.23.51-.21 1.14.01 1.4.48 0 .01 0 .01.01.02.03.06.31.59.34.66zm3.96 12.25c-1.24-.08-2.42-.78-3-1.82-.86-1.55-.19-3.36 1.48-4.04 1.53-.62 2.13-2.27 1.35-3.68-.45-.81-1.28-1.4-2.24-1.6-.05-.08-.41-.77-.46-.86 1.46.1 2.81.91 3.49 2.14 1.01 1.81.23 3.93-1.74 4.73-1.23.51-1.72 1.84-1.09 2.99.11.2.38.29.6.2.18-.07.27-.24.23-.42l1.38 2.36zm2.42 2.45c-.37-.64-3.37-5.75-3.75-6.39.15-.19.36-.35.62-.46.24-.1.47-.21.68-.34.69 1.3 3.08 5.88 3.42 6.53a.87.87 0 01-.45.39c-.19.08-.36.17-.52.27zm1.36 2.31c.05-.17.18-.31.37-.39.17-.07.32-.14.47-.23.13.24.76 1.45 1.89 3.61.01.29-.05.46-.2.52-.21.09-.47 0-.59-.2-.19-.33-1.75-2.98-1.94-3.31zm.46 2.45c-.84-.11-1.59-.6-1.99-1.32-.63-1.14-.14-2.48 1.09-2.98.95-.38 1.32-1.41.84-2.28a.485.485 0 00-.55-.22c-.08-.16-.74-1.41-.82-1.57.91.15 1.73.7 2.16 1.47.71 1.28.16 2.77-1.22 3.33-.8.33-1.12 1.19-.71 1.93.08.14.22.22.37.24.08.14.74 1.26.83 1.4z"}),n.a.createElement("path",{id:"a7XtKqkxY",d:"M522.93 248.85l-.21-.41c-.01-.01-.02-.02-.02-.03-.49-.88-1.65-1.27-2.6-.89-.94.38-1.32 1.41-.83 2.28.01.01.01.03.02.04 0 0 .02.03.05.08-.72.29-1.11.45-1.19.49-.45.18-.78.51-.94.92-.07.16-.56 1.42-.62 1.58-.14.35-.08.74.16 1.06.35.49 1.02.71 1.61.53.03-.01.06-.03.1-.04l.18-.09c.16-.1 1.38-.84 1.53-.93.35-.21.59-.53.71-.89.2.35 1.83 3.11 2.03 3.46-1.03 1.09-1.28 2.71-.48 4.15.42.77 1.1 1.4 1.94 1.81.72.35 1.53.52 2.32.49l1.3 2.2c-.76.87-.93 2.11-.31 3.22.62 1.13 1.91 1.84 3.26 1.82.02.04.2.34.22.37.34.59 1.14.85 1.78.59.64-.26.91-.96.59-1.55-.2-.39-1.81-3.46-2.01-3.84.93-.94 1.16-2.37.46-3.62-.65-1.17-1.98-1.94-3.39-1.99-.34-.65-1.54-2.93-1.71-3.26 1.34-1.24 1.71-3.2.75-4.93-.9-1.61-2.75-2.64-4.7-2.62zm-4.91 4.89a.506.506 0 01-.54-.17.363.363 0 01-.05-.36c.06-.16.56-1.42.62-1.57.08-.23.27-.41.5-.5.08-.04.49-.2 1.21-.49.26.43.4.67.43.72a.37.37 0 00-.16.42c.11.38-.04.77-.39.98-.15.09-1.37.83-1.53.93-.03.02-.06.03-.09.04zm6.32-2.19c.48.35.78.64.92.89.23.41.29.85.21 1.26-.08-.14-.45-.86-1.13-2.15zm-2.08-2.14s.01 0 .01.01c.27.52 2.44 4.67 2.71 5.19a1.9 1.9 0 01-.69.46c-.26.11-.5.24-.73.39-.34-.6-3.14-5.36-3.49-5.96 0-.01-.01-.01-.01-.02-.26-.47-.06-1.02.45-1.23.51-.21 1.14.01 1.4.48 0 .01 0 .01.01.02.03.06.31.59.34.66zm3.96 12.25c-1.24-.08-2.42-.78-3-1.82-.86-1.55-.19-3.36 1.48-4.04 1.53-.62 2.13-2.27 1.35-3.68-.45-.81-1.28-1.4-2.24-1.6-.05-.08-.41-.77-.46-.86 1.46.1 2.81.91 3.49 2.14 1.01 1.81.23 3.93-1.74 4.73-1.23.51-1.72 1.84-1.09 2.99.11.2.38.29.6.2.18-.07.27-.24.23-.42l1.38 2.36zm2.42 2.45c-.37-.64-3.37-5.75-3.75-6.39.15-.19.36-.35.62-.46.24-.1.47-.21.68-.34.69 1.3 3.08 5.88 3.42 6.53a.87.87 0 01-.45.39c-.19.08-.36.17-.52.27zm1.36 2.31c.05-.17.18-.31.37-.39.17-.07.32-.14.47-.23.13.24.76 1.45 1.89 3.61.01.29-.05.46-.2.52-.21.09-.47 0-.59-.2-.19-.33-1.75-2.98-1.94-3.31zm.46 2.45c-.84-.11-1.59-.6-1.99-1.32-.63-1.14-.14-2.48 1.09-2.98.95-.38 1.32-1.41.84-2.28a.485.485 0 00-.55-.22c-.08-.16-.74-1.41-.82-1.57.91.15 1.73.7 2.16 1.47.71 1.28.16 2.77-1.22 3.33-.8.33-1.12 1.19-.71 1.93.08.14.22.22.37.24.08.14.74 1.26.83 1.4z"}),n.a.createElement("path",{id:"keeLZuPGB",d:"M510.25 237.36c.58.59-.31 1.45-.89.86-.58-.58.31-1.44.89-.86z"}),n.a.createElement("linearGradient",{id:"gradiente1sm04Slrb",x1:"510.25",x2:"509.36",y1:"237.36",y2:"238.22",gradientUnits:"userSpaceOnUse"},n.a.createElement("stop",{offset:"0%",stopOpacity:"0.12"}),n.a.createElement("stop",{offset:"55%",stopOpacity:"0.09"}),n.a.createElement("stop",{offset:"100%",stopOpacity:"0.02"})),n.a.createElement("path",{id:"d2OlHU6f",d:"M510.25 237.36c.58.59-.31 1.45-.89.86-.58-.58.31-1.44.89-.86z"}),n.a.createElement("path",{id:"h1q4qe1SZp",d:"M510.25 237.36c.58.59-.31 1.45-.89.86-.58-.58.31-1.44.89-.86z"}),n.a.createElement("path",{id:"b1D15EcfvJ",d:"M510.25 237.36c.58.59-.31 1.45-.89.86-.58-.58.31-1.44.89-.86z"}),n.a.createElement("path",{id:"aRtihZ7jn",d:"M510.55 238.2c.58.58-.31 1.45-.89.86-.58-.59.3-1.45.89-.86z"}),n.a.createElement("path",{id:"b2qGrbpQ4",d:"M510.55 238.2c.58.58-.31 1.45-.89.86-.58-.59.3-1.45.89-.86z"}),n.a.createElement("path",{id:"c8c7tLDSc",d:"M510.55 238.2c.58.58-.31 1.45-.89.86-.58-.59.3-1.45.89-.86z"}),n.a.createElement("path",{id:"ca6zv15Ag",d:"M510.55 238.2c.58.58-.31 1.45-.89.86-.58-.59.3-1.45.89-.86z"}),n.a.createElement("path",{id:"aChkeSqN7",d:"M511.33 244.45c1.38 1.33 3.37 1.82 5.08 1.45.64-.13.93.87.28 1.01-2.06.45-4.46-.25-6.12-1.84-1.59-1.55-2.25-3.73-1.84-5.62.13-.62 1.17-.24 1.04.37-.34 1.57.24 3.37 1.56 4.63z"}),n.a.createElement("linearGradient",{id:"gradientaYJSFhDgq",x1:"513.38",x2:"510.67",y1:"242.53",y2:"245.16",gradientUnits:"userSpaceOnUse"},n.a.createElement("stop",{offset:"0%",stopOpacity:"0.12"}),n.a.createElement("stop",{offset:"55%",stopOpacity:"0.09"}),n.a.createElement("stop",{offset:"100%",stopOpacity:"0.02"})),n.a.createElement("path",{id:"b7bzr60zQ",d:"M511.33 244.45c1.38 1.33 3.37 1.82 5.08 1.45.64-.13.93.87.28 1.01-2.06.45-4.46-.25-6.12-1.84-1.59-1.55-2.25-3.73-1.84-5.62.13-.62 1.17-.24 1.04.37-.34 1.57.24 3.37 1.56 4.63z"}),n.a.createElement("path",{id:"agpPVlj5R",d:"M511.33 244.45c1.38 1.33 3.37 1.82 5.08 1.45.64-.13.93.87.28 1.01-2.06.45-4.46-.25-6.12-1.84-1.59-1.55-2.25-3.73-1.84-5.62.13-.62 1.17-.24 1.04.37-.34 1.57.24 3.37 1.56 4.63z"}),n.a.createElement("path",{id:"f7RMb4NVk",d:"M511.33 244.45c1.38 1.33 3.37 1.82 5.08 1.45.64-.13.93.87.28 1.01-2.06.45-4.46-.25-6.12-1.84-1.59-1.55-2.25-3.73-1.84-5.62.13-.62 1.17-.24 1.04.37-.34 1.57.24 3.37 1.56 4.63z"}),n.a.createElement("path",{id:"bAskcsz0C",d:"M511.63 245.28c1.38 1.33 3.37 1.83 5.07 1.46.65-.14.93.86.29 1-2.07.45-4.46-.25-6.12-1.84-1.6-1.54-2.25-3.72-1.84-5.62.13-.62 1.17-.24 1.03.38-.33 1.56.25 3.36 1.57 4.62z"}),n.a.createElement("path",{id:"bPl7wsy6a",d:"M511.63 245.28c1.38 1.33 3.37 1.83 5.07 1.46.65-.14.93.86.29 1-2.07.45-4.46-.25-6.12-1.84-1.6-1.54-2.25-3.72-1.84-5.62.13-.62 1.17-.24 1.03.38-.33 1.56.25 3.36 1.57 4.62z"}),n.a.createElement("path",{id:"c1viUFq0Q8",d:"M511.63 245.28c1.38 1.33 3.37 1.83 5.07 1.46.65-.14.93.86.29 1-2.07.45-4.46-.25-6.12-1.84-1.6-1.54-2.25-3.72-1.84-5.62.13-.62 1.17-.24 1.03.38-.33 1.56.25 3.36 1.57 4.62z"}),n.a.createElement("path",{id:"c1hHfxeyo4",d:"M511.63 245.28c1.38 1.33 3.37 1.83 5.07 1.46.65-.14.93.86.29 1-2.07.45-4.46-.25-6.12-1.84-1.6-1.54-2.25-3.72-1.84-5.62.13-.62 1.17-.24 1.03.38-.33 1.56.25 3.36 1.57 4.62z"}),n.a.createElement("path",{id:"dq1p1fT3v",d:"M519.86 248.62c-4.05 2.13-9.2.54-11.5-3.55-2.3-4.08-.88-9.13 3.17-11.26 4.05-2.13 9.21-.54 11.5 3.54 2.3 4.09.88 9.14-3.17 11.27z"}),n.a.createElement("path",{id:"bfHkQu3pd",d:"M519.86 248.62c-4.05 2.13-9.2.54-11.5-3.55-2.3-4.08-.88-9.13 3.17-11.26 4.05-2.13 9.21-.54 11.5 3.54 2.3 4.09.88 9.14-3.17 11.27z"})),n.a.createElement("use",{fill:"#bababa",xlinkHref:"#i1pBFCDxGk"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#i1pBFCDxGk"}),n.a.createElement("use",{fill:"#fff",xlinkHref:"#aFIILHUTY"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#aFIILHUTY"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#e1pUKJlHYS"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#e1pUKJlHYS"}),n.a.createElement("use",{fill:"#fff",xlinkHref:"#bGuKiG5X"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#bGuKiG5X"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#bu63OR5lD"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#bu63OR5lD"}),n.a.createElement("use",{fill:"#fff",xlinkHref:"#cmO7MU26P"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#cmO7MU26P"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#a7mce9hyTE"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#a7mce9hyTE"}),n.a.createElement("use",{fill:"#fff",xlinkHref:"#d5jweFtW6Q"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#d5jweFtW6Q"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#b1JeHIk2qX"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#b1JeHIk2qX"}),n.a.createElement("use",{fill:"#ef5959",xlinkHref:"#a4qCKY8Z4k"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#a4qCKY8Z4k"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#h1QMDcBePp"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#h1QMDcBePp"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#c2MCOs8wsy"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#c2MCOs8wsy"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#a7XtKqkxY"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#a7XtKqkxY"}),n.a.createElement("use",{fill:"url(#gradiente1sm04Slrb)",xlinkHref:"#keeLZuPGB"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#keeLZuPGB"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#d2OlHU6f"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#d2OlHU6f"}),n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#h1q4qe1SZp"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#h1q4qe1SZp"}),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#b1D15EcfvJ"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#b1D15EcfvJ"})),n.a.createElement("g",null,n.a.createElement("use",{fill:"#ef5959",xlinkHref:"#aRtihZ7jn"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#aRtihZ7jn"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#b2qGrbpQ4"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#b2qGrbpQ4"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#c8c7tLDSc"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#c8c7tLDSc"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#ca6zv15Ag"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#ca6zv15Ag"})),n.a.createElement("g",null,n.a.createElement("use",{fill:"url(#gradientaYJSFhDgq)",xlinkHref:"#aChkeSqN7"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#aChkeSqN7"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#b7bzr60zQ"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#b7bzr60zQ"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#agpPVlj5R"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#agpPVlj5R"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#f7RMb4NVk"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#f7RMb4NVk"})),n.a.createElement("g",null,n.a.createElement("use",{fill:"#ef5959",xlinkHref:"#bAskcsz0C"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#bAskcsz0C"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#bPl7wsy6a"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#bPl7wsy6a"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#c1viUFq0Q8"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#c1viUFq0Q8"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#c1hHfxeyo4"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#c1hHfxeyo4"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#dq1p1fT3v"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#000",strokeOpacity:"0",xlinkHref:"#dq1p1fT3v"})),n.a.createElement("g",null,n.a.createElement("use",{fillOpacity:"0",xlinkHref:"#bfHkQu3pd"}),n.a.createElement("use",{fillOpacity:"0",stroke:"#ef5959",strokeWidth:"2",xlinkHref:"#bfHkQu3pd"})))}},208:function(e,t,a){e.exports=a.p+"static/media/tools.9f4fcd85.svg"},218:function(e,t,a){e.exports=a.p+"static/media/logo.min.c1d79895.svg"},237:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0001.8f0a1b12.png"},238:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0002.6778b4e1.png"},239:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0003.095f9f1a.png"},240:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0004.b4b7b10f.png"},241:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0005.cc9e655d.png"},242:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0006.ee29b862.png"},243:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0007.971df785.png"},244:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0008.d6af6e29.png"},245:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0009.afeca25e.png"},246:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0010.c82302e1.png"},247:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0011.fc2392f0.png"},248:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0012.f0ab7a5b.png"},249:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0013.80ab365f.png"},250:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0014.e977a74a.png"},251:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0015.03295ddb.png"},252:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0016.0221215a.png"},253:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0017.adbd54b8.png"},254:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0018.40de8d00.png"},255:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0019.c5318dc9.png"},256:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0020.80fd7ce4.png"},257:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0021.6e570e3f.png"},258:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0022.4ee6f3a6.png"},259:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0023.4c6e0f87.png"},260:function(e,t,a){e.exports=a.p+"static/media/Drugs4Covid-EUvsVirus.pptx_page-0024.a2ed64b9.png"},29:function(e,t,a){"use strict";a.r(t);t.default={MedicineStock:{values:[{Medicine:"TRANGOREX","n\xba Centers":3205},{Medicine:"DOLQUINE","n\xba Centers":2846},{Medicine:"TRANKIMAZIN","n\xba Centers":2032},{Medicine:"TRANKIMAZIN RETARD","n\xba Centers":2979},{Medicine:"MAXALT MAX","n\xba Centers":1820},{Medicine:"PARACETAMOL CINFA EFG","n\xba Centers":1436},{Medicine:"ADOFEN","n\xba Centers":1432},{Medicine:"NITRODERM TTS","n\xba Centers":1031},{Medicine:"DOLOCATIL CODEINA","n\xba Centers":1887},{Medicine:"ELECOR","n\xba Centers":1643}],xField:"Medicine",yField:"n\xba Centers",xAxis:{label:{visible:!1,autoRotate:!0,autoHide:!0}}},pie:{labels:["Ingl\xe9s","Italiano","Espa\xf1ol"],datasets:[{data:[300,50,100],backgroundColor:["#FF6384","#36A2EB","#FFCE56"],hoverBackgroundColor:["#FF6384","#36A2EB","#FFCE56"]}]},ArticlesPerYear:{values:[{year:"1970",value:6},{year:"1971",value:1},{year:"1972",value:4},{year:"1973",value:10},{year:"1974",value:6},{year:"1975",value:12},{year:"1976",value:17},{year:"1977",value:23},{year:"1978",value:25},{year:"1979",value:30},{year:"1980",value:29},{year:"1981",value:51},{year:"1982",value:39},{year:"1983",value:54},{year:"1984",value:57},{year:"1985",value:73},{year:"1986",value:88},{year:"1987",value:104},{year:"1988",value:116},{year:"1989",value:110},{year:"1990",value:115},{year:"1991",value:149},{year:"1992",value:142},{year:"1993",value:129},{year:"1994",value:122},{year:"1995",value:146},{year:"1996",value:107},{year:"1997",value:102},{year:"1998",value:106},{year:"1999",value:102},{year:"2000",value:116},{year:"2001",value:171},{year:"2002",value:154},{year:"2003",value:407},{year:"2004",value:905},{year:"2005",value:961},{year:"2006",value:1079},{year:"2007",value:1163},{year:"2008",value:1318},{year:"2009",value:1492},{year:"2010",value:1573},{year:"2011",value:1764},{year:"2012",value:1859},{year:"2013",value:2071},{year:"2014",value:2232},{year:"2015",value:2438},{year:"2016",value:2588},{year:"2017",value:2592},{year:"2018",value:2822},{year:"2019",value:2919},{year:"2020",value:2478}],xField:"year",yField:"value",xAxis:{type:"time",tickCount:20,mask:"YYYY"}},radar:{labels:["Efecto1","Efecto2","Efecto3","Efecto4","Efecto5","Efecto6","Efecto7"],datasets:[{label:"Medicamento 1",backgroundColor:"rgba(179,181,198,0.2)",borderColor:"rgba(179,181,198,1)",pointBackgroundColor:"rgba(179,181,198,1)",pointBorderColor:"#fff",pointHoverBackgroundColor:"#fff",pointHoverBorderColor:"rgba(179,181,198,1)",data:[65,59,90,81,56,55,40]},{label:"Medicamento 2",backgroundColor:"#0A7AA360",borderColor:"#60a5ff",pointBackgroundColor:"#60a5ff",pointBorderColor:"#fff",pointHoverBackgroundColor:"#fff",pointHoverBorderColor:"#60a5ff",data:[28,48,40,19,96,27,100]}]},donut:{labels:["RDF","PDF","JSON","CSV","TXT"],datasets:[{data:[150,210,300,50,100],backgroundColor:["#FF6384","#36A2EB","#FFCE56","#acbea3","#a2666f"],hoverBackgroundColor:["#FF6384","#36A2EB","#FFCE56","#acbea3","#a2666f"]}]},bubble:{labels:["January"],datasets:[{label:"Nombre comercial: KALETRA",fill:!1,lineTension:.1,backgroundColor:"#ff003794",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"#fa541c",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"#fa541c",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:15,y:50,r:35},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]},{label:"Principio activo: LOPINAVIR",fill:!1,lineTension:.1,backgroundColor:"rgba(244, 77, 59, 0.6)",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"rgba(75,192,192,1)",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"rgba(75,192,192,1)",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:15,y:75,r:55},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]},{label:"Principio activo: RITONAVIR",fill:!1,lineTension:.1,backgroundColor:"rgba(147, 12, 196, 0.5)",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"rgba(75,192,192,1)",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"rgba(75,192,192,1)",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:25,y:80,r:55},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]},{label:"Grupo terap\xe9utico: J05AR10",fill:!1,lineTension:.1,backgroundColor:"#008f7ab3",borderColor:"rgba(75,192,192,1)",borderDash:[],borderDashOffset:0,borderJoinStyle:"miter",pointBorderColor:"rgba(75,192,192,1)",pointBackgroundColor:"#fff",pointBorderWidth:1,pointHoverRadius:5,pointHoverBackgroundColor:"rgba(75,192,192,1)",pointHoverBorderColor:"rgba(220,220,220,1)",pointHoverBorderWidth:2,pointRadius:1,pointHitRadius:10,data:[{x:22,y:40,r:45},{x:0,y:0,r:0},{x:0,y:100,r:0},{x:50,y:0,r:0},{x:50,y:100,r:0}]}]},graph:{nodes:[{id:"Harry"},{id:"Sally"},{id:"Alice"}],links:[{source:"Harry",target:"Sally"},{source:"Harry",target:"Alice"}]},graphConfig:{node:{color:"lightgreen",size:500,highlightStrokeColor:"blue"},link:{highlightColor:"lightblue"}},teamData:[{source:"teamImages/Fotos/OscarCorcho.jpeg",name:"Oscar Corcho",role:"Promoter",group:"Support",institution:"UPM",twitter:"ocorcho",github:"ocorcho",linkedin:"https://www.linkedin.com/in/ocorcho/",email:"ocorcho@fi.upm.es"},{source:"teamImages/Fotos/asuncion.jpg",name:"Asun G\xf3mez-P\xe9rez",role:"Promoter",group:"Support",institution:"UPM",twitter:"asungomezperez",github:"",linkedin:"http://www.dia.fi.upm.es/es/asun",email:"asun@fi.upm.es"},{source:"teamImages/Fotos/DavidChaves.jpg",name:"David Chaves",role:"Knowledge Engineer",group:"KG",institution:"UPM",twitter:"dchavesf",github:"dachafra",linkedin:"https://www.linkedin.com/in/david-chaves-fraga/",email:"dchaves@fi.upm.es"},{source:"teamImages/Fotos/CarlosBadenesOlmedo.png",name:"Carlos Badenes-Olmedo",role:"Product Owner",group:"NLP",institution:"UPM",twitter:"carbadol",github:"cbadenes",linkedin:"https://www.linkedin.com/in/cbadenes",email:"cbadenes@fi.upm.es"},{source:"teamImages/Fotos/luisPozo.png",name:"Luis Pozo",role:"Developer",group:"DEV",institution:"UPM",twitter:"LuispozoDev",github:"w0xter",linkedin:"https://www.linkedin.com/in/luis-pozo-472b6317a/",email:"luis.pozo@upm.es"},{source:"teamImages/Fotos/PatriciaMart\xednChozas.png",name:"Patricia Mart\xedn-Chozas",role:"Linguist",group:"NLP",institution:"UPM",twitter:"pmchozas",github:"pmchozas",linkedin:"https://www.linkedin.com/in/pmchozas/",email:"pmchozas@fi.upm.es"},{source:"teamImages/Fotos/MariaPoveda.jpg",name:"Mar\xeda Poveda-Villal\xf3n",role:"Ontologist",group:"KG",institution:"UPM",twitter:"MariaPovedaV",github:"mariapoveda",linkedin:"https://www.linkedin.com/in/mpovedavillalon",email:"mpoveda@fi.upm.es"},{source:"teamImages/Fotos/AlbaFernandez.png",name:"Alba Fern\xe1ndez-Izquierdo",role:"Ontologist",group:"KG",institution:"UPM",twitter:"albafizq",github:"albaizq",linkedin:"https://www.linkedin.com/in/albafernandezizquierdo/",email:"albafernandez@fi.upm.es"},{source:"teamImages/Fotos/AnaIglesiasMolina.jpg",name:"Ana Iglesias-Molina",role:"Knowledge Engineer",group:"KG",institution:"UPM",twitter:"_aieme",github:"anaigmo",linkedin:"https://www.linkedin.com/in/ana-iglesias-molina/",email:"ana.iglesiasm@upm.es"},{source:"teamImages/Fotos/PaolaEspinozaArias.jpg",name:"Paola Espinoza-Arias",role:"Ontologist",group:"KG",institution:"UPM",twitter:"mijaspao",github:"paoespinozarias",linkedin:"https://www.linkedin.com/in/paolaespinoza-arias/",email:"pespinoza@fi.upm.es"},{source:"teamImages/Fotos/PabloCallejaIba\xf1ez.jpg",name:"Pablo Calleja Ib\xe1\xf1ez",role:"Computational Linguistic",group:"NLP",institution:"UPM",twitter:"SPabloCalleja",github:"serpablo",linkedin:"https://www.linkedin.com/in/pablo-calleja-ib%C3%A1%C3%B1ez-63799064/",email:"pcalleja@fi.upm.es"},{source:"teamImages/Fotos/VirginiadePablo.png",name:"Virginia de Pablo",role:"Comunicaci\xf3n",group:"Support",institution:"UPM",twitter:"v_depablo",github:"",linkedin:"https://www.linkedin.com/in/vdepablo/",email:"vdepablo@fi-upm.es"},{source:"teamImages/Fotos/DanielBermejoS\xe1nchez.jpg",name:"Daniel Bermejo S\xe1nchez",role:"Back End Programmer",group:"CS",institution:"UPM",twitter:"",github:"",linkedin:"https://www.linkedin.com/in/daniel-bermejo-s\xe1nchez-020712160",email:"daniel.bermejos@alumnos.upm.es"},{source:"teamImages/Fotos/ElviraAmador.JPG",name:"Elvira Amador Dom\xednguez",role:"Machine Learning Engineer",group:"NLP",institution:"UPM",twitter:"elviamador",github:"eamadord",linkedin:"https://www.linkedin.com/in/elvira-amador-dom%C3%ADnguez-746607116/",email:"eamador@fi.upm.es"},{source:"teamImages/Fotos/EdnaRuckhaus.png",name:"Edna Ruckhaus Magnus",role:"Knowledge Graph exploitation",group:"KG",institution:"UPM",twitter:"eruckhaus",github:"ednaru",linkedin:"https://www.linkedin.com/in/eruckhaus/",email:"eruckhaus@fi.upm.es"},{source:"teamImages/Fotos/SocorroBernardos.png",name:"Socorro Bernardos Galindo",role:"Ayuda en ontolog\xeda y consultas",group:"KG",institution:"UPM",twitter:"",github:"",linkedin:"",email:""},{source:"teamImages/Fotos/EstebanGonz\xe1lezGuardia.jpeg",name:"Esteban Gonz\xe1lez Guardia",role:"Frontend programmer",group:"CS",institution:"UPM",twitter:"eglezguardia",github:"esgg",linkedin:"",email:"egonzalez@fi.upm.es"},{source:"teamImages/Fotos/BeatrizL\xf3pezCenteno.jpg",name:"Beatriz L\xf3pez Centeno",role:"Hospital Pharmacist",group:"Support",institution:"SERMAS",twitter:"blopezcenteno",github:"",linkedin:"https://www.linkedin.com/in/blopezcenteno/",email:"blcenteno@salud.madrid.org"},{source:"teamImages/Fotos/JU_N.jpg",name:"Juan Utande",role:"Advisor",group:"Support",institution:"UPM",twitter:"jutande",github:"",linkedin:"https://www.linkedin.com/in/juan-utande/",email:"jutande@fi.upm.es"},{source:"teamImages/Fotos/MaydadePabloLlorente.png",name:"Mayda de Pablo Llorente",role:"Support",group:"Support",institution:"",twitter:"maydadepablo",github:"",linkedin:"https://www.linkedin.com/in/maydadepablo/",email:"mayda.depablo.llorente@alumnos.upm.es"}],languages:[{info:{title1:"DRUGS4COVID",text1:"Estamos creando un cat\xe1logo de medicamentos que est\xe1n siendo utilizados para combatir la COVID-19. Para ello, utilizamos la literatura cient\xedfica sobre coronavirus existente (m\xe1s de 60.000 art\xedculos) y utilizamos t\xe9cnicas de Inteligencia Artificial y Ciencia Ciudadana.",videoLink:"https://www.youtube.com/embed/uaaFqRV-NKU"},problems:{title0:"Problema",title1:"Las reservas de medicamentos en los servicios de farmacia de los hospitales se est\xe1n agotando",text1:"Con el aumento del n\xfamero de pacientes afectados por la COVID-19 e ingresados en las Unidades de Cuidados Intensivos en todo el mundo, se ha incrementado la demanda de los medicamentos necesarios para su tratamiento. A pesar de que muchos laboratorios han aumentado la producci\xf3n, sigue habiendo problemas de suministro, como se puede comprobar en la Web de la Agencia Espa\xf1ola de Medicamentos y Productos Sanitarios.\nDurante a\xf1os, se ha generado una gran cantidad de literatura cient\xedfica sobre coronavirus (ahora mismo, m\xe1s de 60.000 art\xedculos cient\xedficos), lo que es de gran ayuda para esta labor, pero a la vez hace dif\xedcil la exploraci\xf3n, m\xe1xime teniendo en cuenta que un mismo principio activo puede aparecer mencionado con m\xe1s de un nombre comercial.",graph1:{title:"Farmacias sin Stock de cierto medicamento",subtitle:"N\xfamero de farmacias sin stock de un medicamento espec\xedfico desde el 23/03/2020 hasta el 29/03/2020"}},resources:{title0:"Tanta informaci\xf3n se convierte en un nuevo problema",title1:"CORD-19",text1:"Por tanto, esta gran riqueza de documentaci\xf3n cient\xedfica supone al mismo tiempo un problema para encontrar lo que se busca, sobre todo en una situaci\xf3n en la que el tiempo con el que contamos es a veces tan corto.\nSi alguien quiere conocer la aplicaci\xf3n o uso de un medicamento en el tratamiento de la COVID-19 para un grupo espec\xedfico de pacientes, o identificar las relaciones entre medicamentos descritos en un protocolo de actuaci\xf3n, debe navegar por este gran corpus de documentaci\xf3n donde los medicamentos aparecen mencionados con distintos nombres (principio activo, nombre comercial, grupo terape\xfatico, etc.). Adem\xe1s, en ocasiones la menci\xf3n de un medicamento en un art\xedculo cient\xedfico nos proporciona informaci\xf3n muy relevante sobre su posible utilizaci\xf3n, pero en otros casos puede tratarse de una frase sin relevancia para nuestro objetivo, que es el de salvar vidas.",graph1:{title:"Art\xedculos por a\xf1o",subtitle:"N\xfamero de publicaciones desde 1976 hasta febrero de 2020"},graphtext1:"Muchas fuentes entre las que consultar.",graphtext2:"La nomenclatura de los medicamentos var\xeda seg\xfan el contexto.",title2:"Algunos datos:"},approach:{title0:"Nuestro Enfoque",text1:"\xbfC\xf3mo funciona?",data:[{step:1,title:"Procesar",content:"Procesar e indexar el corpus de publicaciones cient\xedficas, y todos sus p\xe1rrafos.",source:"approach/file_searching.svg",info:{motivation:{title:"Motivaci\xf3n",text:"En este paso de nuestra metodolog\xeda necesitamos facilitar el procesamiento autom\xe1tico de todas las publicaciones cient\xedficas disponibles en el corpus seleccionado (en nuestro caso, el CORD-19)"},problems:{title:"Problemas",text:"Afortunadamente, la informaci\xf3n sobre todas las publicaciones de este corpus est\xe1 disponible de manera abierta y sencilla, a trav\xe9s de varias colecciones de documentos comprimidas (formato GZ) y con un archivo con metainformaci\xf3n (formato CSV), que debemos tratar adecuadamente."},hypothesis:{title:"Hip\xf3tesis",text:"Almacenar los art\xedculos en repositorios orientados a documentos permitir\xe1 que puedan ser procesados y anotados autom\xe1ticamente mediante su interfaz de acceso HTTP."},methodology:{title:"Metodolog\xeda",lists:[[{type:"link",link:"https://pages.semanticscholar.org/coronavirus-research",text:"Descargar corpus CORD-19"},{type:"value",text:"Descargar metadatos en formato CSV"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'Commercial use subset' (16763 art\xedculos en formato JSON)"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'Non-commercial use subset ' (4228 art\xedculos en formato JSON)"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'Custom license subset ' (19171 art\xedculos en formato JSON)"},{type:"value",text:"Descargar art\xedculos de la colecci\xf3n 'bioRxiv/medRxiv subset' (500 art\xedculos en formato JSON)"},{type:"value",text:"Creaci\xf3n \xedndice en Solr para almacenar los art\xedculos"},{type:"value",text:"Desarrollo c\xf3digo Python para lectura de art\xedculos y registro en \xedndice en Solr"},{type:"value",text:"Segmentaci\xf3n de art\xedculos en frases"},{type:"value",text:"Creaci\xf3n \xedndice en Solr para almacenar los frases"},{type:"value",text:"Desarrollo c\xf3digo Python para extracci\xf3n de frases a partir del texto de los art\xedculos y registro en \xedndice en Solr"},{type:"value",text:"Creaci\xf3n de visualizaciones estad\xedsticas para la exploraci\xf3n de los art\xedculos"}]]},results:{title:"Resultados",lists:[[{type:"link",text:"Repositorio de documentos",link:"http://librairy.linkeddata.es/data/#/covid/core-overview"},{type:"link",text:"Repositorio de frases",link:"http://librairy.linkeddata.es/data/#/covid-sentences/core-overview"},{type:"link",text:"Visualizaci\xf3n Repositorio (c\xf3digo GIST 4f726911fd9908ffc3a46837b15d8011)",link:"https://librairy.linkeddata.es/data/dashboard"},{type:"link",text:"Exploraci\xf3n guiada por art\xedculos relacionados a partir de su contenido y sus anotaciones",link:"https://librairy.github.io/covid19/explorer.html"},{type:"link",text:"C\xf3digo de Python para el indexado",link:"https://github.com/librairy/covid19/blob/master/parallel-index-articles.py"}]]},conclusions:{title:"Conclusiones",statistics:{"Art\xedculos Indexados":"33244","Frases Extra\xeddas Autom\xe1ticamente":"5298063"}}}},{step:2,title:"Clasificar",content:"Anotar cada art\xedculo y cada frase con la informaci\xf3n procesada.",source:"approach/annotation.svg",info:{motivation:{title:"Motivaci\xf3n",text:"Agrupar medicamentos relacionados en el tratamiento del COVID para poder utilizarlos en situaciones de desabastecimiento."},problems:{title:"Problemas",text:"text",lists:[[{type:"value",text:"Procesamiento masivo de Art\xedculos cient\xedficos"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de medicamentos"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de s\xedntomas"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de enfermedades"},{type:"value",text:"Identificaci\xf3n autom\xe1tica de trastornos"}],{title:"Descubrimiento de relaciones:",data:[{type:"value",text:"Medicamento vs S\xedntoma"},{type:"value",text:"Medicamento vs Enfermedad"},{type:"value",text:"Medicamento vs Trastorno"}]}]},hypothesis:{title:"Hip\xf3tesis",text:"La caracterizaci\xf3n de medicamentos mediante s\xedntomas, enfermedades y trastornos extra\xeddos autom\xe1ticamente de la literatura cient\xedfica permitir\xe1 agrupar aquellos que est\xe9n relacionados."},methodology:{title:"Metodolog\xeda",lists:[[{type:"link",text:"Creaci\xf3n servicio identificaci\xf3n medicamentos y c\xf3digos ATC",link:"http://librairy.github.io/bio-nlp"},{type:"value",text:"Desarrollo y ejecuci\xf3n de un anotador de enfermedades y medicamentos basado en modelos de identificaci\xf3n de entidades (NER). Anotaci\xf3n a dos niveles de profundidad: frase y art\xedculo"},{type:"value",text:"Construcci\xf3n de modelos de agrupamiento global y jer\xe1rquico a partir de las representaciones de los medicamentos obtenidas con las anotaciones."}],{title:"Evaluaci\xf3n de los resultados obtenidos:",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_2.png",text:"Para 100 Grupos (0.436208445103141)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_3.png",text:"Para 110 Grupos (0.4494331459873356)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_4.png",text:"Para 120 Grupos (0.4576435692957037)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_5.png",text:"Para 130 Grupos (0.4553701275038375)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_6.png",text:"Para 140 Grupos (0.46024923069398316)"}]}]},results:{title:"Resultados",lists:[{title:"Anotaciones: 5.274.655 frases y 33.244 art\xedculos",data:[{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_diseases_t",text:"Enfermedades (scipacy_diseases_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_problems_t",text:"S\xedntomas (annot_cliner_problems_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_treatments_t",text:"Trastornos (annot_cliner_treatments_t)"},{type:"title",text:"Medicamentos:"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_chemicals_t",text:"sustancia qu\xedmica: (scispacy_chemicals_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc5_t",text:"principio activo (bionlp_atc5_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc4_t",text:"grupo terape\xfatico (bionlp_atc4_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc3_t",text:"grupo qu\xedmico (bionlp_atc3_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc2_t",text:"grupo farmacol\xf3gico (bionlp_atc2_t)"},{type:"image",text:"",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/annotations-donut2.png"}]},{title:"Distribuci\xf3n de los medicamentos a partir de las anotaciones",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-bidimensional-latest.png",text:"En espacio bi-dimensional"},{type:"image",link:"https://raw.githubusercontent.com/oeg-upm/drugs4covid19web/master/web/src/assets/approach/drugs-atc5-dendrogram-latest.png",text:"Por niveles"}]}]},conclusions:{title:"Conclusiones",lists:[[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-cluster-latest.png",text:"Se han identificado 120 grupos de medicamentos de entre todos los mencionados en art\xedculos publicados en CORD-19"},{type:"value",text:"A partir de un medicamento, ya sea desde su nombre comercial, grupo farmacol\xf3gico, terape\xfatico o principio activo, se pueden sugerir medicamentos relacionados."},{type:"value",text:"Se pueden realizar b\xfasquedas basadas en enfermedades, s\xedntomas, tratamientos o medicamentos de los art\xedculos cient\xedficos publicados en CORD-19."},{type:"link",caption:"(Los medicamentos que combinan la actividad inmunosupresora y antimal\xe1rica tienen el principio activo P01BA02; los antibi\xf3ticos macr\xf3lidos pertenecen al grupo terape\xfatico J01FA)",link:"https://librairy.linkeddata.es/solr/covid/select?fl=url_s%2C%20name_s%2C%20scispacy_diseases_t&q=labels4_t%3AJ01FA%20AND%20labels5_t%3AP01BA02",text:"Por ejemplo, responder a la siguiente pregunta: \xbfse han usado medicamentos que combinan actividad inmunosupresora y antimal\xe1rica con antibi\xf3ticos macr\xf3lidos? \xbfEn qu\xe9 documentos se mencionan, y relacionados con qu\xe9 enfermedades?"},{type:"image",link:"https://taiga.vencealvirus.software.imdea.org/media/attachments/7/4/2/c/88032427ea5df8abb15780aed503ade41f27500d1dbe735178f6f96e8986/diseaseschemicals-atcs2.png#_taiga-refresh=wiki_page:1361",text:"No todas las frases pertenecientes al corpus contienen entidades de relevancia, y en la gran mayor\xeda solo aparece 1"},{type:"value",text:"No se detallan suficientes relaciones entre entidades a nivel de frase. Otras tareas adicionales como la identificaci\xf3n de correferencias para trabajar a nivel de p\xe1rrafo y generaci\xf3n de nuevos modelos para el corpus espec\xedfico se contemplan como l\xedneas futuras"}],{title:"Medicamentos relacionados con el Aciclovir (J05AB01) en este contexto",data:[{type:"value",link:"",text:"ketamine (N01AX03)"},{type:"value",link:"",text:"piperazine (P02CB01)"},{type:"value",link:"",text:"acefylline piperazine (R03DA09)"},{type:"value",link:"",text:"barium sulfate without suspending agents (V08BA02)"},{type:"value",link:"",text:"barium sulfate with suspending agents (V08BA01)"},{type:"value",link:"",text:"chlorhexidine (S01AX09, S03AA04, S02AA09, D09AA12, R02AA05, B05CA02, D08AC02, A01AB03)"},{type:"value",link:"",text:"chlorhexidine, combinations (D08AC52)"},{type:"value",link:"",text:"artesunate (P01BE03)"},{type:"value",link:"",text:"artesunate and pyronaridine (P01BF06)"},{type:"value",link:"",text:"amodiaquine (P01BA06)"}]}]}}},{step:3,title:"Validar",content:"Revisar estas anotaciones con la ayuda de cient\xedficos ciudadanos.",source:"approach/medical_research.svg",info:{motivation:{title:"Motivaci\xf3n",text:"Validar las frases extra\xeddas de los art\xedculos que tratan sobre el COVID-19 por ciudadanos con formaci\xf3n y conocimientos en Ciencias de la Salud."},problems:{title:"Problemas",text:"Las palabras clave relacionadas con la enfermedad (s\xedntomas, medicamentos, enfermedades y tratamientos) pueden aparecer en las frases en diferente orden y con un significado distinto, por lo que es dif\xedcil una interpretaci\xf3n autom\xe1tica."},hypothesis:{title:"Hip\xf3tesis",text:"El conocimiento e interpretaci\xf3n de los ciudadanos con formaci\xf3n y conocimientos en Ciencias de la Salud ser\xe1 clave para validar las frases extra\xeddas de los art\xedculos cient\xedficos que realiza el procesamiento autom\xe1tico."},methodology:{title:"Metodolog\xeda",lists:[[{type:"value",text:"Se construir\xe1 un experimento de ciencia ciudadana, a modo de aplicaci\xf3n web, que permita a los usuarios con formci\xf3n y conocimientos en ciencias de la salud validar las frases extra\xeddas por el sistema de Inteligencia Artificial."},{type:"value",text:"Los datos de entrada del experimento ser\xe1n las frases extra\xeddas del procesamiento autom\xe1tico."},{type:"value",text:"En cumplimiento de la GDPR, se informar\xe1 al usuario sobre c\xf3mo se van a tratar sus datos personales, derecho a creaci\xf3n de perfiles autom\xe1ticos y derecho al borrado cuando el usuario lo estime adecuado. Adem\xe1s, los datos permanecer\xe1n en servidores debidamente securizados."},{type:"value",text:"Todos los datos en bruto \xbfdel experimento? se publicar\xe1n en abierto, anonimizando previamente el identificador del usuario."}],{title:"La aplicaci\xf3n permitir\xe1:",data:[{type:"value",text:"Registrar usuarios y clasificarlos seg\xfan perfil (m\xe9dicos de familia, enfermeros, epidemi\xf3logos, farmac\xe9uticos, \u2026). Dicha clasificaci\xf3n se realizar\xe1 mediante la realizaci\xf3n de un tutorial"},{type:"value",text:"Se mostrar\xe1 al usuario una frase extra\xedda del corpus y marcar\xe1 en ella los s\xedntomas, medicamentos y posibles tratamientos."},{type:"value",text:"La aplicaci\xf3n registrar\xe1 cada una de las palabras o grupos de palabras marcadas por los usuarios."},{type:"value",text:"Los datos validados se enviar\xe1n a una API para su almacenamiento en una base de datos."},{type:"value",text:'Se calcular\xe1 un \xedndice de confianza para cada usuario, basado en "gold standards" (tareas previamente validadas por los expertos).'},{type:"link",link:"https://oeg-upm.github.io/drugs4covid19-cs/",text:"Prueba aqu\xed nuestro demo"}]}]},conclusions:{title:"Conclusi\xf3n",lists:[[{type:"value",text:"Conjunto y clasificaci\xf3n de los medicamentos adecuados para la enfermedad."},{type:"value",text:"Conjunto y clasificaci\xf3n de los s\xedntomas de la enfermedad."},{type:"value",text:"Relaci\xf3n s\xedntomas-medicamentos extra\xeddos de las frases."},{type:"value",text:"Relaci\xf3n medicamento-medicamento."},{type:"value",text:"Relaci\xf3n medicamento-enfermedad."}]]},results:{}}},{step:4,title:"Publicar",content:"Publicar un grafo de conocimientos con los datos que sean correctos.",source:"approach/kg.svg",info:{motivation:{title:"Motivaci\xf3n",text:"A partir del Corpus corpus CORD-19, un corpus actualizado de art\xedculos cient\xedficos sobre COVID-19 se han generado varios repositorios orientados a documentos que pueden ser procesados y anotados autom\xe1ticamente mediante su interfaz de acceso HTTP. El repositorio generado de frases de estos art\xedculos contiene anotaciones acerca de enfermedades, s\xedntomas y trastornos y tratamientos (c\xf3digos ATC) relacionados con el COVID-19. Actualmente existen diferentes repositorios de datos relacionados con estos aspectos que contienen una descripci\xf3n detallada de atributos tales como todos los nombres con los que se conoce una medicina, efectos secundarios, entre otros. Se quiere entonces extender las anotaciones generadas inicialmente con aquellas generadas por este tipo de relaciones. Para que la informaci\xf3n pueda ser explotada por tanto por personas vinculadas al \xe1mbito sanitario como por el p\xfablico en general, es necesario que las anotaciones est\xe9n alineadas a un vocabulario que describa este dominio del conocimiento. De esta manera, el repositorio original ser\xe1 transformado a un grafo de conocimiento (knowledge graph) mediante t\xe9cnicas que trabajan con mappings (correspondencias) entre el repositorio de frases y el vocabulario desarrollado."},problems:{title:"Problemas",lists:[[{type:"value",text:"Silos de informaci\xf3n"},{type:"value",text:"Fuentes de datos heterog\xe9neas"},{type:"value",text:"Diversidad de formatos y m\xe9todos de consulta"},{type:"value",text:"Carencia de vocabularios consensuados"}]]},hypothesis:{title:"Hip\xf3tesis",text:"Un punto de acceso \xfanico y unificado en forma de grafo permite recuperar informaci\xf3n sobre los medicamentos y sus interacciones de forma m\xe1s efectiva para los expertos."},methodology:{title:"Metodolog\xeda",lists:[[{type:"value",text:"B\xfasqueda y generaci\xf3n de fuentes de datos"},{type:"value",text:"B\xfasqueda de fuentes de conocimiento relacionadas a enfermedades, s\xedntomas y trastornos, tratamientos."},{type:"value",text:"Explorar otros repositorios sem\xe1nticos que han sido generados a partir de informaci\xf3n de COVID-19 para ver la posibilidad de relacionar los grafos de conocimiento."},{type:"value",text:"Generaci\xf3n del vocabulario con reuso de ontolog\xedas asociadas a esas fuentes."},{type:"value",text:"Documentaci\xf3n y publicaci\xf3n del vocabulario."},{type:"value",text:"Mapeo de los datos al vocabulario."},{type:"value",text:"Generaci\xf3n del grafo de conocimiento alineado con vocabulario."},{type:"value",text:"Enriquecimiento del grafo con validaciones de expertos (ciencia ciudadana)."},{type:"value",text:"Publicaci\xf3n del grafo de conocimiento"}]]},results:{title:"Resultados",lists:[[{type:"link",link:"https://w3id.org/def/DRUGS4COVID19",text:"Vocabulario"},{type:"link",link:"https://github.com/oeg-upm/drugs4covid19-kg",text:"Knowledge graph"},{type:"link",link:"http://librairy.linkeddata.es/sparql",text:"Punto de consulta"},{type:"link",link:"https://librairy.linkeddata.es/sparql?default-graph-uri=http%3A%2F%2Fdrugs4covid.com%2F542020&query=select+distinct+*+where+%7B%0D%0A%0D%0A%3Fs+a+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%23Paper%3E.%0D%0A%3Fs+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%2Fmenciona%3E+%3Fa+.%0D%0A%3Fa+%3Fp+%3Ft+.%0D%0A%0D%0A%7D+limit+10&should-sponge=&format=text%2Fhtml&timeout=0&debug=on&run=+Run+Query+",text:"Ejemplo de consulta"}]]},conclusions:{title:"Conclusiones",text:"Hemos integrado de forma estructurada la informaci\xf3n sacada de las art\xedculos cient\xedficos, sus anotaciones y adem\xe1s la hemos enriquecido con enlaces \xfatiles para los expertos a fuentes externas. De esta manera, esta fuente de informaci\xf3n \xfanica se puede utilizar para responder preguntas de forma r\xe1pida y sencilla."}}}]},tools:{title0:"Apps desarrolladas por Drugs4Covid",title1:"D4C Search Engine",text1:"Un servicio web abierto, donde explotar la literatura cient\xedfica sobre el Coronavirus (m\xe1s de 60.000 art\xedculos). Identificando medicamentos, enfermedades y art\xedculos y mostrando las relaciones que existen entre ellos dentro del corpus. Puedes buscar por c\xf3digo ATC, c\xf3digo MESH, nombre gen\xe9rico o nombre de enfermedad.",title2:"D4C Knowledge Graph Interface",text2:"Una interfaz web de nuestro Grafo de Conocimiento, donde puedes crear tus propias consultas o ejecutar algunas de las consultas que hemos formulado con la ayuda de doctores e investigadores que quer\xedan obtener informaci\xf3n sobre del corpus.",title3:"D4C Query Builder",text3:"Una web donde aprender como interactuar con la API de Drugs4Covid para hacer tus propios experimentos.",link1:"https://bio-nlp-dashboard.netlify.app/",link2:"https://kg.drugs4covid.oeg-upm.net/",link3:"https://bio-nlp-dashboard.netlify.app/customsearch"},team:{title0:"\xbfQui\xe9nes Somos?",title1:"El Equipo",title2:"Con la ayuda de:",logo1:"logos/oeg.jpg",logo2:"logos/upm.png",logo3:"logos/FacInformatica.jpg"}},{info:{title1:"DRUGS4COVID",text1:"We are creating a catalogue of medicines that are being used to combat COVID-19. Using Artificial Intelligence techniques and Citizen Science, we exploit the existing scientific literature about coronavirus (more than 60,000 papers)",videoLink:"https://www.youtube.com/embed/uaaFqRV-NKU"},problems:{title0:"Problem",title1:"Drugs in hospital pharmacy services are running low",text1:"With the increase in the number of patients affected by COVID-19 and admitted to Intensive Care Units throughout the world, the demand for the medicines necessary for their treatment has increased. Laboratories have increased production. However, Drug Agencies worldwide confirm that there are problems related to the supply of some specific medicines.\nFor years, a large amount of scientific literature about coronavirus (currently, more than 60,000 scientific papers) has been generated. This is a great help for eveybody fighting against COVID-19, but at the same time such a large corpus is difficult to explore. Furthermore, the same active ingredient may be found in more than one trade name, what makes exploration of this corpus even more difficult for those who have to make quick informed decisions related to medicine use and supplies.",graph1:{title:"Pharmacies without stock of a medicine",subtitle:"Number of pharmacies in Spain without stock of a specific medicine from 2020-03-23 to 2020-03-29"}},resources:{title0:"So much information becomes problematic",title1:"CORD-19",text1:"Therefore, the large amount of scientific documentation available becomes a problem on itself, especially in situations when decisions have to be made quickly.\nIf a person wants to know the application or use of a drug in the treatment of COVID-19 for a specific group of patients, or identify the relationships between drugs described in a protocol of action, they should navigate this large body of documentation where drugs are often mentioned with different names (active principle, trade name, therapeutic group, etc.). Furthermore, the mention of a medicine in a scientific paper may inform about its possible use, but sometimes it may be also inside a sentence or paragraph that has no relevance to our objective of saving lives.",title2:"Some Data:",graph1:{title:"Articles per year",subtitle:"Number of published articles from 1970 to February 2020."},graphtext1:"Too many sources to consult.",graphtext2:"The name of the medicine depends on the context."},approach:{title0:"Our Approach",text1:"How does it work?",data:[{step:1,title:"Process",content:"Process and index the corpus of scientific papers, and all of its paragraphs.",source:"approach/file_searching.svg",info:{motivation:{title:"Motivation",text:"In this step of our methodology, we want to ease the automatic processing of all the scientific publications available in the corpus (in our case, CORD-19)."},problems:{title:"Problems",text:"Fortunately, the information about all the publications in this corpus is available openly, through several compressed collections of documents (GZ format) and a metadata file (CSV format), which we need to process adequately."},hypothesis:{title:"Hypothesis",text:"Storing the papers in document oriented repositories will allow their automatic processing and annotation through an HTTP access interface."},methodology:{title:"Methodology",lists:[[{type:"link",link:"https://pages.semanticscholar.org/coronavirus-research",text:"Download CORD-19 corpus"},{type:"value",text:"Download metadata in CSV"},{type:"value",text:"Download papers from the collection \u201cCommercial use subset\u201d (16763 papers in JSON)"},{type:"value",text:"Download papers from the collection \u201cNon-commercial use subset\u201d (4228 papers in JSON)"},{type:"value",text:"Download papers from the collection \u201cCustom license subset\u201d (19171 papers in JSON)"},{type:"value",text:"Download papers from \u201cbioRxiv/medRxiv subset\u201d (500 art\xedculos en formato JSON)"},{type:"value",text:"Creation of a Solr index to store the papers"},{type:"value",text:"Development of a Python script for paper reading and registration in the Solr index"},{type:"value",text:"Segmentation of papers in sentences"},{type:"value",text:"Creation of a Solr index to store the sentences"},{type:"value",text:"Development of a Python script to extract sentences from papers and registration in Solr index"},{type:"value",text:"Creation of statistical visualisations for paper exploration"}]]},results:{title:"Results",lists:[[{type:"link",text:"Document repository",link:"http://librairy.linkeddata.es/data/#/covid/core-overview"},{type:"link",text:"Sentence repository",link:"http://librairy.linkeddata.es/data/#/covid-sentences/core-overview"},{type:"link",text:"Visualisation repository (code: GIST 4f726911fd9908ffc3a46837b15d8011)",link:"https://librairy.linkeddata.es/data/dashboard"},{type:"link",text:"Guided exploration accross the related papers based on their content and annotations",link:"https://librairy.github.io/covid19/explorer.html"},{type:"link",text:"Python script for indexing",link:"https://github.com/librairy/covid19/blob/master/parallel-index-articles.py"}]]},conclusions:{title:"Conclusions",statistics:{"Indexed Papers":"33244","Automatically Extracted Sentences":"5298063"}}}},{step:2,title:"Classify",content:"Annotate each article and each sentence with the processed information.",source:"approach/annotation.svg",info:{motivation:{title:"Motivation",text:"Grouping drugs related with COVID 19 treatment to use them in shortage situations"},problems:{title:"Problems",text:"text",lists:[[{type:"value",text:"Massive processing of scientific papers"},{type:"value",text:"Automatic drug identification"},{type:"value",text:"Automatic symptom identification"},{type:"value",text:"Automatic disease identification"},{type:"value",text:"Automatic disorder identification"}],{title:"Relation Extraction:",data:[{type:"value",text:"Drug vs Symptom"},{type:"value",text:"Drug vs Disease"},{type:"value",text:"Drug vs Disorder"}]}]},hypothesis:{title:"Hypothesis",text:"The description of drugs by means of symptoms, diseases and disorders automatically extracted from the scientific publication will allow grouping those that are related."},methodology:{title:"Methodology",lists:[[{type:"link",text:"Creation of a service to identify drugs and ATC codes",link:"http://librairy.github.io/bio-nlp"},{type:"value",text:"Development and execution of a drug and disease annotator based of NER models."},{type:"value",text:"Annotations in two levels: sentence and paper."},{type:"value",text:"Generation of grouping models (global and hierarchical) apart from representations of the drugs obtained with the annotations."}],{title:"Evaluation of the results obtained:",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_2.png",text:"For 100 Groups (0.436208445103141)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_3.png",text:"For 110 Groups (0.4494331459873356)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_4.png",text:"For 120 Groups (0.4576435692957037)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_5.png",text:"For 130 Groups (0.4553701275038375)"},{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/silouette-latest_6.png",text:"For 140 Groups (0.46024923069398316)"}]}]},results:{title:"Results",lists:[{title:"Annotations: 5.274.655 sentences y 33.244 papers",data:[{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_diseases_t",text:"Diseases (scipacy_diseases_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_problems_t",text:"Symptoms (annot_cliner_problems_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid/terms?terms.fl=annot_cliner_treatments_t",text:"Disorders (annot_cliner_treatments_t)"},{type:"title",text:"Drugs:"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=scispacy_chemicals_t",text:"chemical substance: (scispacy_chemicals_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc5_t",text:"active ingredient: (bionlp_atc5_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc4_t",text:"therapeutic group: (bionlp_atc4_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc3_t",text:"chemical group: (bionlp_atc3_t)"},{type:"link",link:"http://librairy.linkeddata.es/data/covid-sentences/terms?terms.fl=bionlp_atc2_t",text:"pharmacological group: (bionlp_atc2_t)"},{type:"image",text:"",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/annotations-donut2.png"}]},{title:"Distribution of drugs from annotations",data:[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-bidimensional-latest.png",text:"Bidimensional space"},{type:"image",link:"https://raw.githubusercontent.com/oeg-upm/drugs4covid19web/master/web/src/assets/approach/drugs-atc5-dendrogram-latest.png",text:"By levels"}]}]},conclusions:{title:"Conclusions",lists:[[{type:"image",link:"https://raw.githubusercontent.com/librairy/covid19/master/atc-codes/drugs-atc5-cluster-latest.png",text:"We have identified 120 groups of drugs amongst those mentioned in papers published in CORD-19"},{type:"value",text:"Given a drug, we can suggest related drugs based on its commercial name, pharmacological group, therapeutic group or active ingredient."},{type:"value",text:"We can make searches based on diseases, symptoms, treatments or drugs from the scientific papers published in CORD-19."},{type:"link",caption:"(Los medicamentos que combinan la actividad inmunosupresora y antimal\xe1rica tienen el principio activo P01BA02; los antibi\xf3ticos macr\xf3lidos pertenecen al grupo terape\xfatico J01FA)",link:"https://librairy.linkeddata.es/solr/covid/select?fl=url_s%2C%20name_s%2C%20scispacy_diseases_t&q=labels4_t%3AJ01FA%20AND%20labels5_t%3AP01BA02",text:"For instance, we can now answer to the next question: Have drugs that combine immunosuppressive and anti-malarial activity with macrolide antibiotic been used? In which papers are they mentioned? To which diseases are they related?"},{type:"image",link:"https://taiga.vencealvirus.software.imdea.org/media/attachments/7/4/2/c/88032427ea5df8abb15780aed503ade41f27500d1dbe735178f6f96e8986/diseaseschemicals-atcs2.png#_taiga-refresh=wiki_page:1361",text:"Not all the sentences belonging to this corpus contain relevant entities, and in the major part of the papers only one entity can be found."},{type:"value",text:"No se detallan suficientes relaciones entre entidades a nivel de frase. Otras tareas adicionales como la identificaci\xf3n de correferencias para trabajar a nivel de p\xe1rrafo y generaci\xf3n de nuevos modelos para el corpus espec\xedfico se contemplan como l\xedneas futuras"}],{title:"Drugs related with Aciclovir (J05AB01) in this context",data:[{type:"value",link:"",text:"ketamine (N01AX03)"},{type:"value",link:"",text:"piperazine (P02CB01)"},{type:"value",link:"",text:"acefylline piperazine (R03DA09)"},{type:"value",link:"",text:"barium sulfate without suspending agents (V08BA02)"},{type:"value",link:"",text:"barium sulfate with suspending agents (V08BA01)"},{type:"value",link:"",text:"chlorhexidine (S01AX09, S03AA04, S02AA09, D09AA12, R02AA05, B05CA02, D08AC02, A01AB03)"},{type:"value",link:"",text:"chlorhexidine, combinations (D08AC52)"},{type:"value",link:"",text:"artesunate (P01BE03)"},{type:"value",link:"",text:"artesunate and pyronaridine (P01BF06)"},{type:"value",link:"",text:"amodiaquine (P01BA06)"}]}]}}},{step:3,title:"Validate",content:"Review these notes with the help of citizen scientists.",source:"approach/medical_research.svg",info:{motivation:{title:"Motivation",text:"Validation of the sentences extracted from the papers that contain information about COVID-19 by citizens with knowledge in Health Science."},problems:{title:"Problems",text:"Keywords related with the disease (symptoms, drugs, diseases and treatments) can appear in different order and with a different meaning. Thus, the automatic identification is complex."},hypothesis:{title:"Hypothesis",text:"The knowledge and interpretation of citizens with experience in Health Science will be essential to validate the automatically extracted sentences from scientific papers."},methodology:{title:"Methodology",lists:[[{type:"value",text:"A web application on citizen science will be built. This application will allow the validation of the sentences extracted with an Artificial Intelligence system by users with experience in Health Science."},{type:"value",text:"The input data of the experiment will be the automatically extracted sentences."},{type:"value",text:"In compliance with the GDPR, users will be informed about the treatment of their personal data, the creation of automatic profiles and their right to delete them. Moreover, the servers will be duly secured."},{type:"value",text:"All the raw data from the experiment will be openly published (anonymising previously the user identifiers)."}],{title:"The application will allow:",data:[{type:"value",text:"Registration and classification of users as per their profile (general doctors, nurses, epidemiologists, pharmacists\u2026) Such classification will be made by performing a tutorial."},{type:"value",text:"A phrase extracted from the corpus will be shown to the user and will mark the symptoms, medications and possible treatments."},{type:"value",text:"The users will be shown a sentence extracted from the corpus and they will identify symptoms, drugs and treatments."},{type:"value",text:"Validated data will be sent to an API for their storage in a database."},{type:"value",text:"A confidence index will be calculated for every user, based on gold standards (tasks previously validated by experts)."},{type:"link",link:"https://oeg-upm.github.io/drugs4covid19-cs/",text:"Try here our demo."}]}]},results:{},conclusions:{title:"Conclusions",lists:[[{type:"value",text:"Collection and classification of adequate drugs for the disease."},{type:"value",text:"Collection and classification of symptoms of the disease."},{type:"value",text:"Relations symptom-drug extracted from the sentences."},{type:"value",text:"Relations drug-drug extracted from the sentences."},{type:"value",text:"Relations drug-disease extracted from the sentences."}]]}}},{step:4,title:"Publish",content:"Publish a knowledge graph with the valid data.",source:"approach/kg.svg",info:{motivation:{title:"Motivation",text:"Several document oriented repositories have been generated from the corpus CORD-19, an updated corpus of scientific papers in COVID-19. Documents can be automatically processed and annotated thanks to the HTTP access interface. The generated repository contains sentences from these papers annotated with diseases, symptoms, disorders and treatments (ATC codes) related with COVID-19. There currently are different repositories of related data that contain detailed descriptions of attributes such as the name of a drug or secondary effects, amongst others. Therefore, the idea is to extend initial annotations with those generated by this type of relations. In order to exploit the information, both for health science related people and general audience, the annotations need to be aligned with a vocabulary that describes the knowledge of the domain. This way, the original repository will be transformed into a knowledge graph by means of mappings between the sentence repository and the developed vocabulary."},problems:{title:"Problems",lists:[[{type:"value",text:"Information silos"},{type:"value",text:"Heterogeneous data sources"},{type:"value",text:"Heterogeneous formats and query methods"},{type:"value",text:"Lack of consolidated vocabularies"}]]},hypothesis:{title:"Hypothesis",text:"A unique and unified access point, graph shaped, allows an effective retrieval of information about drugs and their interactions."},methodology:{title:"Methodology",lists:[[{type:"value",text:"Search and generation of data sources"},{type:"value",text:"Search of knowledge sources related to drugs, symptoms, disorders and treatments"},{type:"value",text:"Exploration of other semantic repositories, generated with information on COVID-19, to research on the possibility of mapping knowledge graphs."},{type:"value",text:"Generation of the vocabulary by reusing ontologies associated to that sources."},{type:"value",text:"Documentation and publication of the vocabulary."},{type:"value",text:"Mapping the data with the vocabulary"},{type:"value",text:"Generation of the knowledge graph aligned with the vocabulary"},{type:"value",text:"Enrichment of the graph with expert validations (citizen science)"},{type:"value",text:"Publication of the knowledge graph"}]]},results:{title:"Results",lists:[[{type:"link",link:"https://w3id.org/def/DRUGS4COVID19",text:"Vocabulary"},{type:"link",link:"https://github.com/oeg-upm/drugs4covid19-kg",text:"Knowledge graph"},{type:"link",link:"http://librairy.linkeddata.es/sparql",text:"Sparql endpoint"},{type:"link",link:"https://librairy.linkeddata.es/sparql?default-graph-uri=http%3A%2F%2Fdrugs4covid.com%2F542020&query=select+distinct+*+where+%7B%0D%0A%0D%0A%3Fs+a+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%23Paper%3E.%0D%0A%3Fs+%3Chttps%3A%2F%2Fw3id.org%2Fdef%2FDRUGS4COVID19%2Fmenciona%3E+%3Fa+.%0D%0A%3Fa+%3Fp+%3Ft+.%0D%0A%0D%0A%7D+limit+10&should-sponge=&format=text%2Fhtml&timeout=0&debug=on&run=+Run+Query+",text:"Query example"}]]},conclusions:{title:"Conclusions",text:"We have integrated and structured information extracted from scientific papers and their annotations. Moreover, we have enriched them with links to external resources, which is very useful for experts. This way, this unique information resource can be used to easily answer questions."}}}]},tools:{title0:"Apps powered by Drugs4Covid",title1:"D4C Search Engine",text1:"An open web service to exploit the existing scientific literature about coronavirus (more than 60,000 papers) identifying drugs, diseases and articles and displaying their relations inside the corpus. You can search by ATC code, Generic Name, Disease Name or MESH code.",title2:"D4C Knowledge Graph Interface",text2:"A Knowledge Graph interface to run your own queries or run some examples of questions doctors and researchers might find useful.",title3:"D4C Query Builder",text3:"A simple interface to learn how to use the D4C Api and start to run your own experiments.",link1:"https://bio-nlp-dashboard.netlify.app/",link2:"https://kg.drugs4covid.oeg-upm.net/",link3:"https://bio-nlp-dashboard.netlify.app/customsearch"},team:{title0:"Who Are We?",title1:"The Team",title2:"With the help of:",logo1:"logos/oeg.jpg",logo2:"logos/upm.png",logo3:"logos/FacInformatica.jpg"}}],navText:[{introduction:"Introduction",problem:"Problem",resources:"Resources",approach:"Approach",tools:"Tools",team:"Who Are We?",lang:"ES"},{introduction:"Introducci\xf3n",problem:"Problema",resources:"Recursos",approach:"Nuestro Enfoque",tools:"Herramientas",team:"\xbfQui\xe9nes Somos?",lang:"EN"}],List:{title:"Lopinavir + Ritonavir",items:[{title:"Active principie",description:"Lopinavir + Ritonavir"},{title:"ATC code",description:"J05AR10"},{title:"Trade name",description:"KALETRA 100 mg/25 mg"},{title:"Trade name",description:"LOPINAVIR/RITONAVIR ACCORD 200 MG/ 50 MG"},{title:"Trade name",description:"LOPINAVIR/RITONAVIR RANBAXY 100 MG/25 MG"}]}}},353:function(e,t,a){e.exports=a(788)},358:function(e,t,a){},359:function(e,t,a){e.exports=a.p+"static/media/logo.5d5d9eef.svg"},450:function(e,t){},451:function(e,t){},452:function(e,t){},453:function(e,t){},454:function(e,t){},462:function(e,t,a){var i={"./Drugs4Covid-EUvsVirus.pptx_page-0001.png":237,"./Drugs4Covid-EUvsVirus.pptx_page-0002.png":238,"./Drugs4Covid-EUvsVirus.pptx_page-0003.png":239,"./Drugs4Covid-EUvsVirus.pptx_page-0004.png":240,"./Drugs4Covid-EUvsVirus.pptx_page-0005.png":241,"./Drugs4Covid-EUvsVirus.pptx_page-0006.png":242,"./Drugs4Covid-EUvsVirus.pptx_page-0007.png":243,"./Drugs4Covid-EUvsVirus.pptx_page-0008.png":244,"./Drugs4Covid-EUvsVirus.pptx_page-0009.png":245,"./Drugs4Covid-EUvsVirus.pptx_page-0010.png":246,"./Drugs4Covid-EUvsVirus.pptx_page-0011.png":247,"./Drugs4Covid-EUvsVirus.pptx_page-0012.png":248,"./Drugs4Covid-EUvsVirus.pptx_page-0013.png":249,"./Drugs4Covid-EUvsVirus.pptx_page-0014.png":250,"./Drugs4Covid-EUvsVirus.pptx_page-0015.png":251,"./Drugs4Covid-EUvsVirus.pptx_page-0016.png":252,"./Drugs4Covid-EUvsVirus.pptx_page-0017.png":253,"./Drugs4Covid-EUvsVirus.pptx_page-0018.png":254,"./Drugs4Covid-EUvsVirus.pptx_page-0019.png":255,"./Drugs4Covid-EUvsVirus.pptx_page-0020.png":256,"./Drugs4Covid-EUvsVirus.pptx_page-0021.png":257,"./Drugs4Covid-EUvsVirus.pptx_page-0022.png":258,"./Drugs4Covid-EUvsVirus.pptx_page-0023.png":259,"./Drugs4Covid-EUvsVirus.pptx_page-0024.png":260};function n(e){var t=r(e);return a(t)}function r(e){if(!a.o(i,e)){var t=new Error("Cannot find module '"+e+"'");throw t.code="MODULE_NOT_FOUND",t}return i[e]}n.keys=function(){return Object.keys(i)},n.resolve=r,e.exports=n,n.id=462},710:function(e,t,a){e.exports=a.p+"static/media/annotation.2c34bd7f.svg"},711:function(e,t,a){e.exports=a.p+"static/media/collecting.new.9c5b1003.svg"},712:function(e,t,a){e.exports=a.p+"static/media/collecting.a457acbb.svg"},713:function(e,t,a){e.exports=a.p+"static/media/detailed_analysis.new.051a5c5c.svg"},714:function(e,t,a){e.exports=a.p+"static/media/detailed_analysis.36330695.svg"},715:function(e,t,a){e.exports=a.p+"static/media/drugs-atc5-dendrogram-latest.374a5347.png"},716:function(e,t,a){e.exports=a.p+"static/media/file_searching.cef1e739.svg"},717:function(e,t,a){e.exports=a.p+"static/media/file_system.c122b42a.svg"},718:function(e,t,a){e.exports=a.p+"static/media/files.74273f56.svg"},719:function(e,t,a){e.exports=a.p+"static/media/kg.38378845.svg"},720:function(e,t,a){e.exports=a.p+"static/media/medical_research.new.e507ee0f.svg"},721:function(e,t,a){e.exports=a.p+"static/media/medical_research.c8aab4c4.svg"},722:function(e,t,a){e.exports=a.p+"static/media/professor.new.84d78ec7.svg"},723:function(e,t,a){e.exports=a.p+"static/media/professor.c34907f3.svg"},724:function(e,t,a){e.exports=a.p+"static/media/report.new.f2bb8c12.svg"},725:function(e,t,a){e.exports=a.p+"static/media/report.f9ffaeee.svg"},726:function(e,t,a){e.exports=a.p+"static/media/reviewed_docs.new.951838fc.svg"},727:function(e,t,a){e.exports=a.p+"static/media/reviewed_docs.9899b647.svg"},728:function(e,t,a){e.exports=a.p+"static/media/undraw_annotation_7das.2bf1faf6.svg"},729:function(e,t,a){e.exports=a.p+"static/media/undraw_collecting_fjjl.a457acbb.svg"},730:function(e,t,a){e.exports=a.p+"static/media/undraw_detailed_analysis_xn7y.36330695.svg"},731:function(e,t,a){e.exports=a.p+"static/media/undraw_medical_research_qg4d.fba35ee6.svg"},732:function(e,t,a){e.exports=a.p+"static/media/undraw_professor_8lrt.c34907f3.svg"},733:function(e,t,a){e.exports=a.p+"static/media/undraw_report_mx0a.f9ffaeee.svg"},734:function(e,t,a){e.exports=a.p+"static/media/undraw_reviewed_docs_neeb.9899b647.svg"},735:function(e,t,a){e.exports=a.p+"static/media/logo.white.94d3e461.svg"},736:function(e,t,a){e.exports=a.p+"static/media/FacInformatica.c48fb5ab.jpg"},737:function(e,t,a){e.exports=a.p+"static/media/Logo_OEG.bc48c89c.jpg"},738:function(e,t,a){e.exports=a.p+"static/media/image.5799dfff.png"},739:function(e,t,a){e.exports=a.p+"static/media/oeg.33852d44.jpg"},740:function(e,t,a){e.exports=a.p+"static/media/upm.4d109cc0.png"},741:function(e,t){e.exports="data:image/png;base64,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"},742:function(e,t,a){e.exports=a.p+"static/media/AlbaFernandez.e7eaf598.png"},743:function(e,t,a){e.exports=a.p+"static/media/AnaIglesiasMolina.2926a2ea.jpg"},744:function(e,t,a){e.exports=a.p+"static/media/BeatrizL\xf3pezCenteno.e57035b2.jpg"},745:function(e,t,a){e.exports=a.p+"static/media/CarlosBadenesOlmedo.ae9fdc03.png"},746:function(e,t){e.exports="data:image/jpeg;base64,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"},747:function(e,t){e.exports="data:image/jpeg;base64,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"},748:function(e,t,a){e.exports=a.p+"static/media/EdnaRuckhaus.70f588f2.png"},749:function(e,t,a){e.exports=a.p+"static/media/ElviraAmador.9dc2ccf1.JPG"},750:function(e,t,a){e.exports=a.p+"static/media/EstebanGonz\xe1lezGuardia.92ac2690.jpeg"},751:function(e,t,a){e.exports=a.p+"static/media/Ignacio-IkerPrado-Rujas.147a354f.jpg"},752:function(e,t,a){e.exports=a.p+"static/media/JU_N.9c44f944.jpg"},753:function(e,t){e.exports="data:image/jpeg;base64,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"},754:function(e,t,a){e.exports=a.p+"static/media/MaydadePabloLlorente.51d8e4c8.png"},755:function(e,t,a){e.exports=a.p+"static/media/OscarCorcho.173cb033.jpeg"},756:function(e,t,a){e.exports=a.p+"static/media/PabloCallejaIba\xf1ez.0ee93c97.jpg"},757:function(e,t){e.exports="data:image/jpeg;base64,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"},758:function(e,t,a){e.exports=a.p+"static/media/PatriciaMart\xednChozas.ec10b577.png"},759:function(e,t,a){e.exports=a.p+"static/media/SocorroBernardos.847bee12.png"},760:function(e,t,a){e.exports=a.p+"static/media/VirginiadePablo.5ba516bb.png"},761:function(e,t){e.exports="data:image/jpeg;base64,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"},762:function(e,t,a){e.exports=a.p+"static/media/luisPozo.87e62936.png"},763:function(e,t,a){e.exports=a.p+"static/media/yoHead.2caa6138.png"},781:function(e,t,a){},788:function(e,t,a){"use strict";a.r(t);var i=a(1),n=a.n(i),r=a(7),o=a.n(r),s=(a(358),a(344)),l=a(74),c=(a(359),a(310),a(20)),d=a(21),p=a(83),u=a(22),A=a(23),m=(a(360),a(29)),g=a(108),y=a.n(g),f=(a(218),a(805)),h=a(792),x=a(793),v=a(802),b=a(114),E=a(115),k=a(311),D=a(807),w=("ES"!==document.location.href.toString().slice(-2)?m.default.navText[0]:m.default.navText[1],function(e){Object(A.a)(a,e);var t=Object(u.a)(a);function a(e){var i;return Object(c.a)(this,a),(i=t.call(this,e)).state={text:"ES"!==document.location.href.toString().slice(-2)?m.default.navText[0]:m.default.navText[1],collapsed:!0,activeKey:"introduction"},i.handleSetActive=i.handleSetActive.bind(Object(p.a)(i)),i}return Object(d.a)(a,[{key:"changeLang",value:function(){document.location.href="/lang/".concat(this.state.text.lang)}},{key:"handleSetActive",value:function(e){this.setState({activeKey:e})}},{key:"render",value:function(){var e=this,t=Object.keys(this.state.text),a=t.indexOf("lang");return a>-1&&t.splice(a,1),n.a.createElement(f.a,null,n.a.createElement(h.a,{gutter:[16,16],style:{background:"#fff"}},n.a.createElement(x.a,{md:8},n.a.createElement("img",{src:y.a,className:"img-fluid d-inline-block align-top",alt:"",style:{height:50}})),n.a.createElement(x.a,{xs:2,md:16},n.a.createElement(v.a,{selectedKeys:[this.state.activeKey],mode:"horizontal",style:{borderBottom:"none"},overflowedIndicator:n.a.createElement(D.a,null)},t.map((function(t){return n.a.createElement(v.a.Item,{key:t},n.a.createElement(k.Link,{activeClass:"active",spy:!0,hashSpy:!0,smooth:!0,duration:500,to:t,onSetActive:e.handleSetActive},e.state.text[t]))})),n.a.createElement(v.a.Item,{className:"Item",key:"lang"},n.a.createElement(b.a,{title:"Translate to "+this.state.text.lang},n.a.createElement(E.a,{type:"secondary",onClick:function(){return e.changeLang()}},this.state.text.lang)))))))}}]),a}(n.a.Component)),j=a(806);function C(){return n.a.createElement("div",{className:"mt-xs-3 mt-md-5"},n.a.createElement(h.a,{justify:"",align:"middle"},n.a.createElement(x.a,{xs:12},n.a.createElement("div",{className:"m-2"},n.a.createElement("img",{src:y.a,alt:"DRUGS4COVID",style:{height:50},className:"img-fluid"}))),n.a.createElement(x.a,{xs:12},n.a.createElement(h.a,{style:{float:"right"}},n.a.createElement(x.a,null,n.a.createElement(b.a,{title:"@oeg_upm"},n.a.createElement("a",{target:"_blank",href:"https://twitter.com/oeg_upm?s=20"},n.a.createElement("h3",{className:"blue"},n.a.createElement(j.a,null)))))))))}function O(e){return n.a.createElement(h.a,{type:"flex",justify:"center"},n.a.createElement(x.a,{xs:22,md:20,xl:18},n.a.createElement(w,null),e.children,n.a.createElement(C,null)))}var I=a(799),B=a(801),M=a(794),N=(a(441),a(117)),H=["Drugs4Covid-EUvsVirus.pptx_page-0001.png","Drugs4Covid-EUvsVirus.pptx_page-0002.png","Drugs4Covid-EUvsVirus.pptx_page-0003.png","Drugs4Covid-EUvsVirus.pptx_page-0004.png","Drugs4Covid-EUvsVirus.pptx_page-0005.png","Drugs4Covid-EUvsVirus.pptx_page-0006.png","Drugs4Covid-EUvsVirus.pptx_page-0007.png","Drugs4Covid-EUvsVirus.pptx_page-0008.png","Drugs4Covid-EUvsVirus.pptx_page-0009.png","Drugs4Covid-EUvsVirus.pptx_page-0010.png","Drugs4Covid-EUvsVirus.pptx_page-0011.png","Drugs4Covid-EUvsVirus.pptx_page-0012.png","Drugs4Covid-EUvsVirus.pptx_page-0013.png","Drugs4Covid-EUvsVirus.pptx_page-0014.png","Drugs4Covid-EUvsVirus.pptx_page-0015.png","Drugs4Covid-EUvsVirus.pptx_page-0016.png","Drugs4Covid-EUvsVirus.pptx_page-0017.png","Drugs4Covid-EUvsVirus.pptx_page-0018.png","Drugs4Covid-EUvsVirus.pptx_page-0019.png","Drugs4Covid-EUvsVirus.pptx_page-0020.png","Drugs4Covid-EUvsVirus.pptx_page-0021.png","Drugs4Covid-EUvsVirus.pptx_page-0022.png","Drugs4Covid-EUvsVirus.pptx_page-0023.png","Drugs4Covid-EUvsVirus.pptx_page-0024.png"],U=a(462),S=(I.a.Title,I.a.Text),V=(I.a.Paragraph,function(e){Object(A.a)(a,e);var t=Object(u.a)(a);function a(e){var i;return Object(c.a)(this,a),(i=t.call(this,e)).showModal=function(){i.setState({visible:!0})},i.handleOk=function(e){console.log(e),i.setState({visible:!1})},i.handleCancel=function(e){console.log(e),i.setState({visible:!1})},i.onDocumentLoadSuccess=function(e){var t=e.numPages;console.log("loaded!"),i.setState({numPages:t})},i.state={visible:!1,numPages:null,pageNumber:1},i.carousel=n.a.createRef(),i}return Object(d.a)(a,[{key:"next",value:function(){this.carousel.next()}},{key:"previous",value:function(){this.carousel.prev()}},{key:"render",value:function(){var e=this;return n.a.createElement(n.a.Fragment,null,n.a.createElement(h.a,{align:"middle",gutter:[16,16]},n.a.createElement(x.a,null,n.a.createElement(S,{strong:!0},"Here you can check our ",n.a.createElement("a",{href:"https://twitter.com/EUvsVirus",target:"_blank"},"#EUvsVirus Hackathon")," Status Update"))),n.a.createElement(h.a,{align:"middle",gutter:[16,16]},n.a.createElement(x.a,null,n.a.createElement(E.a,{type:"primary",onClick:function(){return e.showModal()}},"Play ",n.a.createElement(N.d,null))),n.a.createElement(x.a,null,n.a.createElement(E.a,{href:"https://delicias.dia.fi.upm.es/nextcloud/index.php/s/b3q6rpyyPfis8FF/download"},"Download ",n.a.createElement(N.c,null)))),n.a.createElement(h.a,null,n.a.createElement(x.a,{span:24},n.a.createElement(B.a,{title:"EUvsVirus Status Update",visible:this.state.visible,onOk:this.handleOk,onCancel:this.handleCancel,footer:null,width:1e3},n.a.createElement(h.a,{align:"middle"},n.a.createElement(x.a,{span:1,style:{cursor:"pointer"},onClick:function(){return e.previous()}},n.a.createElement("h3",null,n.a.createElement(N.a,null))),n.a.createElement(x.a,{span:22},n.a.createElement(M.a,{ref:function(t){return e.carousel=t},dotPosition:"bottom"},H.map((function(e){return n.a.createElement("div",null,n.a.createElement("img",{key:e,src:U("./"+e),className:"image-fluid mb-3",alt:""}))})))),n.a.createElement(x.a,{span:1,style:{cursor:"pointer"},onClick:function(){return e.next()}},n.a.createElement("h3",null,n.a.createElement(N.b,null))))))))}}]),a}(n.a.Component)),F=a(795),P=I.a.Title,q=I.a.Text;I.a.Paragraph;function z(e){return n.a.createElement("section",{className:"mt-xs-3 mt-md-5"},n.a.createElement(h.a,{gutter:[16,16]},n.a.createElement(x.a,{xs:24,md:14},n.a.createElement(P,{level:2},e.text.title1),n.a.createElement(q,null,e.text.text1)),n.a.createElement(x.a,{xs:24,md:10},n.a.createElement("div",{class:"embed-responsive embed-responsive-16by9"},n.a.createElement("iframe",{class:"embed-responsive-item",src:e.text.videoLink,allowfullscreen:!0})))),n.a.createElement(V,null),n.a.createElement(F.a,null))}var G=a(30);function R(e){var t={title:{visible:!0,text:e.text.title},description:{visible:!0,text:e.text.subtitle},forceFit:!0,data:e.data.values,padding:"auto",xField:e.data.xField,yField:e.data.yField,xAxis:e.data.xAxis,color:"#0A7AA3",label:{visible:!0,style:{fill:"#0A7AA3",fontSize:12,fontWeight:600,opacity:.6}}};return n.a.createElement(G.c,t)}var Q=I.a.Title,J=(I.a.Text,I.a.Paragraph);function W(e){return n.a.createElement("div",{className:"mt-xs-3 mt-md-5"},n.a.createElement(Q,{level:2},e.text.title0),n.a.createElement(h.a,{gutter:[16,16],type:"flex",align:"middle",justify:"center"},n.a.createElement(x.a,{xs:24,md:12},n.a.createElement(Q,{level:4},e.text.title1),n.a.createElement(J,null,e.text.text1)),n.a.createElement(x.a,{xs:24,md:12},n.a.createElement(R,{data:e.data,text:e.text.graph1}))),n.a.createElement(F.a,null))}var T=a(798);function K(e){var t={height:400,title:{visible:!0,text:e.text.title},description:{visible:!0,text:e.text.subtitle},padding:"auto",color:"#0A7AA3",forceFit:!0,xField:e.data.xField,yField:e.data.yField,xAxis:e.data.xAxis,data:e.data.values};return n.a.createElement(G.a,t)}var L=I.a.Title,Z=(I.a.Text,I.a.Paragraph);function Y(e){return n.a.createElement("div",{className:"mt-xs-3 mt-md-5"},n.a.createElement(L,{level:2},e.text.title0),n.a.createElement(h.a,{gutter:[16,16]},n.a.createElement(x.a,{xs:24,md:12},n.a.createElement(L,{level:4},e.text.title1),n.a.createElement(Z,null,e.text.text1))),n.a.createElement(h.a,{gutter:[16,16],align:"bottom",justify:"center"},n.a.createElement(x.a,{xs:24,md:12},n.a.createElement(K,{data:e.data.Line,text:e.text.graph1}),n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,null,n.a.createElement(L,{level:4,type:"secondary"},e.text.graphtext1)))),n.a.createElement(x.a,{xs:24,md:12},n.a.createElement(T.a,{size:"small",header:n.a.createElement(L,{level:4},e.data.List.title),bordered:!0,dataSource:e.data.List.items,renderItem:function(e){return n.a.createElement(T.a.Item,null,n.a.createElement(T.a.Item.Meta,{title:e.title,description:e.description}))}}),n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,null,n.a.createElement(L,{level:4,type:"secondary"},e.text.graphtext2))))),n.a.createElement(F.a,null))}a(617);var X=a(800),_=a(803),$=(n.a.Component,I.a.Text),ee=I.a.Title,te=I.a.Paragraph,ae=(X.a.Tabpane,function(e){var t=e.data;return n.a.createElement("div",null,t.lists.map((function(e,t){var a=!Array.isArray(e)&&Object.keys(e).includes("title")?e.title:"",i=Array.isArray(e)?e:e.data;return n.a.createElement("div",{className:0!==t?"mt-3":""},n.a.createElement(T.a,{bordered:!0,header:""!==a?n.a.createElement($,{strong:!0},a):null,dataSource:i,renderItem:function(e){return n.a.createElement(T.a.Item,null,"link"===e.type?n.a.createElement("a",{href:e.link,target:"_blank"},e.text):"value"===e.type?e.text:"image"===e.type?n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,{className:"text-center"},n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,{className:"text-center"},n.a.createElement($,{strong:!0,style:{whiteSpace:"pre-line"}},e.text))),n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,{className:"text-center"},n.a.createElement("img",{src:e.link,className:"img-fluid",style:{maxWidth:"100%!important"},alt:""}))))):"json"===e.type?n.a.createElement(n.a.Fragment,null,n.a.createElement(h.a,null,n.a.createElement(x.a,{span:24},n.a.createElement($,{strong:!0},e.text)),n.a.createElement(x.a,{span:24},n.a.createElement($,{code:!0},e.code)))):"title"===e.type?n.a.createElement($,{strong:!0},e.text):"")}}))})))}),ie=function(e){Object(A.a)(a,e);var t=Object(u.a)(a);function a(e){var i;return Object(c.a)(this,a),(i=t.call(this,e)).state={motivation:e.motivation,problems:e.problems,methodology:e.methodology,results:e.results,hypothesis:e.hypothesis,conclusions:e.conclusions},i}return Object(d.a)(a,[{key:"render",value:function(){var e=this;return n.a.createElement("div",{className:"py-3"},n.a.createElement("div",null,n.a.createElement(ee,{level:3},this.state.motivation.title),n.a.createElement(te,{className:"text-justify"},this.state.motivation.text)),n.a.createElement("div",null,n.a.createElement(ee,{level:3},this.state.problems.title),Object.keys(this.state.problems).includes("lists")?n.a.createElement(ae,{data:this.state.problems}):n.a.createElement(te,{className:"text-justify"},this.state.problems.text)),n.a.createElement("div",{className:"mt-3"},n.a.createElement(ee,{level:3},this.state.hypothesis.title),n.a.createElement(te,{className:"text-justify"},this.state.hypothesis.text)),n.a.createElement("div",{className:"mt-3"},n.a.createElement(ee,{level:3},this.state.methodology.title),n.a.createElement(ae,{data:this.state.methodology})),0!==Object.keys(this.state.results).length?n.a.createElement("div",{className:"mt-3"},n.a.createElement(ee,{level:3},this.state.results.title),n.a.createElement(ae,{data:this.state.results})):"",0!==Object.keys(this.state.conclusions).length?n.a.createElement("div",{className:"mt-3"},n.a.createElement(ee,{level:3},this.state.conclusions.title),Object.keys(this.state.conclusions).includes("text")?n.a.createElement(te,{className:"text-justify"},this.state.conclusions.text):Object.keys(this.state.conclusions).includes("lists")?n.a.createElement(ae,{data:this.state.conclusions}):n.a.createElement(h.a,{justify:"center",align:"middle",gutter:[16,16]},Object.keys(this.state.conclusions.statistics).map((function(t){return n.a.createElement(x.a,{className:"text-center"},n.a.createElement(_.a,{title:t,precision:2,value:e.state.conclusions.statistics[t]}))})))):"")}}]),a}(n.a.Component),ne=a(138);function re(e){var t=e.data,a=e.buttonText;return console.log(t.info),n.a.createElement("div",{class:"card fullCard"},n.a.createElement("img",{src:ne("./"+t.source),class:"card-img-top img-fluid p-2"}),n.a.createElement("div",{class:"card-body text-left d-flex flex-column"},n.a.createElement("div",{className:"mt-auto"},n.a.createElement("h5",{class:"card-title title pt-2 "},t.step,") ",t.title),n.a.createElement("p",{class:"card-text text-justify montserrat "},t.content))),n.a.createElement("div",{className:"card-footer whiteBg"},n.a.createElement(E.a,{type:"primary",className:"float-right","data-toggle":"modal","data-target":"#modal-"+t.step},a)),n.a.createElement("div",{class:"modal fade",id:"modal-"+t.step,tabindex:"-1",role:"dialog","aria-labelledby":"modal-label-"+t.step,"aria-hidden":"true"},n.a.createElement("div",{class:"modal-dialog modal-xl modal-dialog-scrollable",role:"document"},n.a.createElement("div",{class:"modal-content"},n.a.createElement("div",{class:"modal-header"},n.a.createElement("h2",{class:"modal-title",id:"modal-label-"+t.step},t.title),n.a.createElement("button",{type:"button",class:"close","data-dismiss":"modal","aria-label":"Close"},n.a.createElement("span",{"aria-hidden":"true"},"\xd7"))),n.a.createElement("div",{class:"modal-body  text-left"},n.a.createElement(ie,{motivation:t.info.motivation,hypothesis:t.info.hypothesis,problems:t.info.problems,methodology:t.info.methodology,results:t.info.results,conclusions:t.info.conclusions}))))))}var oe=I.a.Title;I.a.Text,I.a.Paragraph;function se(e){return n.a.createElement(n.a.Fragment,null,n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(oe,{level:2},e.text.title0))),n.a.createElement("div",{className:"card-deck mt-5"},e.data.map((function(t){return n.a.createElement(re,{data:t,buttonText:e.text.text1})}))),n.a.createElement(F.a,null))}var le=a(811),ce=a(808),de=a(809),pe=a(797),ue=a(804),Ae=a(138),me=I.a.Text;function ge(e){var t=e.data,a=(e.gId,{DEV:{tooltip:"Developers Group",color:"magenta"},NLP:{tooltip:"Natural Language Processing Group",color:"purple"},KG:{tooltip:"Knowledge Graph Creation Group",color:"volcano"},Support:{tooltip:"Support and Advisory Group",color:"green"},CS:{tooltip:"Citizen Science Group",color:"cyan"}}),i=0===t.linkedin.length&&0===t.github.length&&0===t.twitter.length&&0===t.email.length;return n.a.createElement(n.a.Fragment,null,n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,null,n.a.createElement(pe.a,{size:150,src:Ae("./"+t.source)}))),n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,{className:"text-center"},n.a.createElement(me,{strong:!0},t.name))),n.a.createElement(h.a,{justify:"center",className:"mt-1"},n.a.createElement(x.a,{className:""},n.a.createElement(b.a,{title:a[t.group].tooltip},n.a.createElement(ue.a,{color:a[t.group].color},t.group))),0!==t.institution.length?n.a.createElement(x.a,{className:""},n.a.createElement(ue.a,{color:{UPM:"#1f82c0",SERMAS:"#d10002"}[t.institution]},t.institution)):""),n.a.createElement(h.a,{justify:"center",gutter:[8,8]},0!==t.twitter.length?n.a.createElement(x.a,null,n.a.createElement("a",{target:"_blank",href:"https://twitter.com/"+t.twitter},n.a.createElement(j.a,null))):"",0!==t.linkedin.length?n.a.createElement(x.a,null,n.a.createElement("a",{target:"_blank",href:t.linkedin},n.a.createElement(le.a,null))):"",0!==t.github.length?n.a.createElement(x.a,null,n.a.createElement("a",{target:"_blank",href:"https://github.com/"+t.github},n.a.createElement(ce.a,null))):"",0!==t.email.length?n.a.createElement(x.a,null,n.a.createElement("a",{target:"_blank",href:"mailto:"+t.email},n.a.createElement(de.a,null))):"",i?n.a.createElement(x.a,null,n.a.createElement(de.a,{style:{opacity:0}})):""))}function ye(e){var t=e.team;return console.log("ESTE EL TEAM"),console.log(t),n.a.createElement(h.a,{gutter:[16,16]},t.map((function(e){return n.a.createElement(x.a,{xs:12,md:8,lg:6,className:"col-xs-6 col-md-4 col-lg-3 py-2 align-self-center"},n.a.createElement(ge,{data:e}))})))}var fe=a(138),he=I.a.Title;I.a.Text,I.a.Paragraph;function xe(e){return n.a.createElement(n.a.Fragment,null,n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(he,{level:2},e.text.title0))),n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(he,{level:4},e.text.title1))),n.a.createElement(h.a,{justify:"center"},n.a.createElement(x.a,null,n.a.createElement(ye,{team:e.data}))),n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(he,{level:4},e.text.title2))),n.a.createElement(h.a,{justify:"center",align:"bottom"},n.a.createElement(x.a,{xs:24,md:8,className:"text-center"},n.a.createElement("img",{src:fe("./"+e.text.logo1),alt:"",className:"img-fluid"})),n.a.createElement(x.a,{xs:24,md:8,className:"text-center"},n.a.createElement("img",{src:fe("./"+e.text.logo2),alt:"",className:"img-fluid"})),n.a.createElement(x.a,{xs:24,md:8,className:"text-center"},n.a.createElement("img",{src:fe("./"+e.text.logo3),alt:"",className:"img-fluid"}))),n.a.createElement(F.a,null))}var ve=a(208),be=a.n(ve),Ee=a(810),ke=(a(200),I.a.Title),De=(I.a.Text,I.a.Paragraph),we=function(e){Object(A.a)(a,e);var t=Object(u.a)(a);function a(e){var i;return Object(c.a)(this,a),(i=t.call(this,e)).state={dots:[]},i.next=i.next.bind(Object(p.a)(i)),i.previous=i.previous.bind(Object(p.a)(i)),i.carousel=n.a.createRef(),i}return Object(d.a)(a,[{key:"next",value:function(){this.carousel.next()}},{key:"previous",value:function(){this.carousel.prev()}},{key:"render",value:function(){return n.a.createElement(n.a.Fragment,null,n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(ke,{level:2},this.props.text.title0))),n.a.createElement(h.a,{align:"middle",className:"mt-5"},n.a.createElement(x.a,{xs:24,md:12},n.a.createElement("img",{src:be.a,alt:"",className:"img-fluid"})),n.a.createElement(x.a,{xs:24,md:12},n.a.createElement("div",null,n.a.createElement(ke,{level:4},this.props.text.title1),n.a.createElement(h.a,null,n.a.createElement(x.a,{xs:24},n.a.createElement(De,{className:"text-justify"},this.props.text.text1))),n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(E.a,{href:this.props.text.link1,size:"large"},"Start to search ",n.a.createElement(Ee.a,null))))),n.a.createElement("div",{className:"mt-3"},n.a.createElement(ke,{level:4},this.props.text.title2),n.a.createElement(h.a,null,n.a.createElement(x.a,{span:24},n.a.createElement(De,{className:"text-justify"},this.props.text.text2))),n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(E.a,{href:this.props.text.link2,size:"large"},"Start to Query")))),n.a.createElement("div",{className:"mt-3"},n.a.createElement(ke,{level:4},this.props.text.title3),n.a.createElement(h.a,null,n.a.createElement(x.a,{span:24},n.a.createElement(De,{className:"text-justify"},this.props.text.text3))),n.a.createElement(h.a,null,n.a.createElement(x.a,null,n.a.createElement(E.a,{href:this.props.text.link3,size:"large"},"Start to Query")))))),n.a.createElement(F.a,null))}}]),a}(n.a.Component);a(138);function je(e){var t=null;try{t=e.match.params.lang}catch(i){console.log(i)}var a="ES"===t?m.default.languages[0]:m.default.languages[1];return n.a.createElement(O,null,n.a.createElement("div",{className:"",id:"introduction"},n.a.createElement(z,{text:a.info})),n.a.createElement("div",{className:"pt-5",id:"problem"},n.a.createElement(W,{text:a.problems,data:m.default.MedicineStock})),n.a.createElement("div",{className:"pt-5",id:"resources"},n.a.createElement(Y,{text:a.resources,data:{Line:m.default.ArticlesPerYear,List:m.default.List}})),n.a.createElement("div",{className:"pt-5",id:"approach"},n.a.createElement(se,{text:a.approach,data:a.approach.data})),n.a.createElement("div",{id:"tools",className:"pt-5"},n.a.createElement(we,{text:a.tools})),n.a.createElement("div",{id:"team",className:"pt-5"},n.a.createElement(xe,{text:a.team,data:m.default.teamData})))}n.a.Component;function Ce(e){return n.a.createElement(n.a.Fragment,null,function(){switch(e.data.type){case"bar":return n.a.createElement(G.b,e.data.config);case"line":return n.a.createElement(G.f,e.data.config);case"area":return n.a.createElement(G.a,e.data.config);case"wordcloud":return n.a.createElement(G.i,e.data.config);case"column":return n.a.createElement(G.c,e.data.config);case"groupedcolumn":return n.a.createElement(G.e,e.data.config);case"gauge":return n.a.createElement(G.d,e.data.config);case"overlappedcombo":return n.a.createElement(G.g,e.data.config);case"stepline":return n.a.createElement(G.h,e.data.config);default:return n.a.createElement("h1",null,"ALGO VA MAL")}}())}a(764);var Oe=function(e){Object(A.a)(a,e);var t=Object(u.a)(a);function a(e){var i;return Object(c.a)(this,a),(i=t.call(this,e)).state={data:[],size:12},i}return Object(d.a)(a,[{key:"render",value:function(){var e=this;return n.a.createElement(n.a.Fragment,null,n.a.createElement(h.a,{justify:"center",align:"middle",gutter:[16,16]},this.state.data.map((function(t){return n.a.createElement(x.a,{className:"text-center p-1",xs:24,md:e.state.size},n.a.createElement(Ce,{data:t}))}))))}},{key:"componentDidMount",value:function(){var e=this;new Promise((function(e,t){e([{type:"line",config:{title:{visible:!0,text:"2000 ~ 2018 "},description:{visible:!0,text:"This is the description"},forceFit:!0,data:[{name:"China",year:"2000",gdp:1211346869605.24},{name:"China",year:"2001",gdp:1339395718865.3},{name:"China",year:"2002",gdp:1470550015081.55},{name:"China",year:"2003",gdp:1660287965662.68},{name:"China",year:"2004",gdp:1955347004963.27},{name:"China",year:"2005",gdp:2285965892360.54},{name:"China",year:"2006",gdp:2752131773355.16},{name:"China",year:"2007",gdp:3550342425238.25},{name:"China",year:"2008",gdp:4594306848763.08},{name:"China",year:"2009",gdp:5101702432883.45},{name:"China",year:"2010",gdp:6087164527421.24},{name:"China",year:"2011",gdp:7551500425597.77},{name:"China",year:"2012",gdp:8532230724141.76},{name:"China",year:"2013",gdp:9570405758739.79},{name:"China",year:"2014",gdp:10438529153237.6},{name:"China",year:"2015",gdp:11015542352468.9},{name:"China",year:"2016",gdp:11137945669350.6},{name:"China",year:"2017",gdp:12143491448186.1},{name:"China",year:"2018",gdp:13608151864637.9},{name:"United States",year:"2000",gdp:0x9530f68d4c0},{name:"United States",year:"2001",gdp:0x99fc5b49fd8},{name:"United States",year:"2002",gdp:0x9f2555f71b0},{name:"United States",year:"2003",gdp:0xa6bd48e5c70},{name:"United States",year:"2004",gdp:0xb1bbafcb878},{name:"United States",year:"2005",gdp:0xbdb544f5688},{name:"United States",year:"2006",gdp:0xc9077018bf0},{name:"United States",year:"2007",gdp:1445185865e4},{name:"United States",year:"2008",gdp:0xd6199d86320},{name:"United States",year:"2009",gdp:0xd24278534e8},{name:"United States",year:"2010",gdp:0xda29bfa2cd8},{name:"United States",year:"2011",gdp:0xe22ca068d80},{name:"United States",year:"2012",gdp:0xebb28de9508},{name:"United States",year:"2013",gdp:1678484919e4},{name:"United States",year:"2014",gdp:0xfef997a5e70},{name:"United States",year:"2015",gdp:18219297584e3},{name:"United States",year:"2016",gdp:18707188235e3},{name:"United States",year:"2017",gdp:19485393853e3},{name:"United States",year:"2018",gdp:20544343456936.5},{name:"United Kingdom",year:"2000",gdp:1657816613708.58},{name:"United Kingdom",year:"2001",gdp:1640246149417.01},{name:"United Kingdom",year:"2002",gdp:1784473920863.31},{name:"United Kingdom",year:"2003",gdp:2053018775510.2},{name:"United Kingdom",year:"2004",gdp:2416931526913.22},{name:"United Kingdom",year:"2005",gdp:253868e7},{name:"United Kingdom",year:"2006",gdp:2713749770009.2},{name:"United Kingdom",year:"2007",gdp:3100882352941.18},{name:"United Kingdom",year:"2008",gdp:2922667279411.76},{name:"United Kingdom",year:"2009",gdp:2410909799034.12},{name:"United Kingdom",year:"2010",gdp:2475244321361.11},{name:"United Kingdom",year:"2011",gdp:2659310054646.23},{name:"United Kingdom",year:"2012",gdp:2704887678386.72},{name:"United Kingdom",year:"2013",gdp:2786022872706.81},{name:"United Kingdom",year:"2014",gdp:3063803240208.01},{name:"United Kingdom",year:"2015",gdp:2928591002002.51},{name:"United Kingdom",year:"2016",gdp:2694283209613.29},{name:"United Kingdom",year:"2017",gdp:2666229179958.01},{name:"United Kingdom",year:"2018",gdp:2855296731521.96},{name:"Russian",year:"2000",gdp:259710142196.94},{name:"Russian",year:"2001",gdp:306602070620.5},{name:"Russian",year:"2002",gdp:345470494417.86},{name:"Russian",year:"2003",gdp:430347770731.79},{name:"Russian",year:"2004",gdp:591016690742.8},{name:"Russian",year:"2005",gdp:764017107992.39},{name:"Russian",year:"2006",gdp:989930542278.7},{name:"Russian",year:"2007",gdp:1299705764823.62},{name:"Russian",year:"2008",gdp:1660846387624.78},{name:"Russian",year:"2009",gdp:1222644282201.86},{name:"Russian",year:"2010",gdp:1524917468442.01},{name:"Russian",year:"2011",gdp:2051661732059.78},{name:"Russian",year:"2012",gdp:2210256976945.38},{name:"Russian",year:"2013",gdp:2297128039058.21},{name:"Russian",year:"2014",gdp:2059984158438.46},{name:"Russian",year:"2015",gdp:1363594369577.82},{name:"Russian",year:"2016",gdp:1282723881134.01},{name:"Russian",year:"2017",gdp:1578624060588.26},{name:"Russian",year:"2018",gdp:1657554647149.87},{name:"Japan",year:"2000",gdp:4887519660744.86},{name:"Japan",year:"2001",gdp:4303544259842.72},{name:"Japan",year:"2002",gdp:4115116279069.77},{name:"Japan",year:"2003",gdp:4445658071221.86},{name:"Japan",year:"2004",gdp:4815148854362.11},{name:"Japan",year:"2005",gdp:4755410630912.14},{name:"Japan",year:"2006",gdp:4530377224970.4},{name:"Japan",year:"2007",gdp:4515264514430.57},{name:"Japan",year:"2008",gdp:5037908465114.48},{name:"Japan",year:"2009",gdp:5231382674593.7},{name:"Japan",year:"2010",gdp:5700098114744.41},{name:"Japan",year:"2011",gdp:6157459594823.72},{name:"Japan",year:"2012",gdp:6203213121334.12},{name:"Japan",year:"2013",gdp:5155717056270.83},{name:"Japan",year:"2014",gdp:4850413536037.84},{name:"Japan",year:"2015",gdp:4389475622588.97},{name:"Japan",year:"2016",gdp:4926667087367.51},{name:"Japan",year:"2017",gdp:4859950558538.97},{name:"Japan",year:"2018",gdp:4971323079771.87}],xField:"year",yField:"gdp",seriesField:"name",xAxis:{type:"dateTime",label:{visible:!0,autoHide:!0}},yAxis:{formatter:function(e){return"".concat((e/1e9).toFixed(1)," B")}},legend:{visible:!1},label:{visible:!0,type:"line"},animation:{appear:{animation:"clipingWithData"}},smooth:!0}},{type:"groupedcolumn",config:{title:{visible:!0,text:"\u5206\u7ec4\u67f1\u72b6\u56fe"},forceFit:!0,data:[{name:"London",month:"Jan.",value:18.9},{name:"London",month:"Feb.",value:28.8},{name:"London",month:"Mar.",value:39.3},{name:"London",month:"Apr.",value:81.4},{name:"London",month:"May",value:47},{name:"London",month:"Jun.",value:20.3},{name:"London",month:"Jul.",value:24},{name:"London",month:"Aug.",value:35.6},{name:"Berlin",month:"Jan.",value:12.4},{name:"Berlin",month:"Feb.",value:23.2},{name:"Berlin",month:"Mar.",value:34.5},{name:"Berlin",month:"Apr.",value:99.7},{name:"Berlin",month:"May",value:52.6},{name:"Berlin",month:"Jun.",value:35.5},{name:"Berlin",month:"Jul.",value:37.4},{name:"Berlin",month:"Aug.",value:42.4}],xField:"month",yField:"value",yAxis:{min:0},label:{visible:!0},groupField:"name",color:["#1ca9e6","#f88c24"]}},{type:"stepline",config:{title:{visible:!0,text:"Random Title"},description:{visible:!0,text:"Random Subtitle"},forceFit:!0,padding:"auto",data:[{year:"1991",value:3},{year:"1992",value:4},{year:"1993",value:3.5},{year:"1994",value:5},{year:"1995",value:4.9},{year:"1996",value:6},{year:"1997",value:7},{year:"1998",value:9},{year:"1999",value:13}],xField:"year",yField:"value",point:{visible:!0},label:{visible:!0,type:"point"}}},{type:"overlappedcombo",config:{layers:[{type:"groupedColumn",name:"\u8ba2\u5355\u91cf",data:[{time:"2019-03",value:350,type:"uv"},{time:"2019-04",value:900,type:"uv"},{time:"2019-05",value:300,type:"uv"},{time:"2019-06",value:450,type:"uv"},{time:"2019-07",value:470,type:"uv"},{time:"2019-03",value:220,type:"bill"},{time:"2019-04",value:300,type:"bill"},{time:"2019-05",value:250,type:"bill"},{time:"2019-06",value:220,type:"bill"},{time:"2019-07",value:362,type:"bill"}],xField:"time",yField:"value",groupField:"type"},{type:"line",name:"\u8f6c\u5316",data:[{time:"2019-03",value:800},{time:"2019-04",value:600},{time:"2019-05",value:400},{time:"2019-06",value:380},{time:"2019-07",value:220}],xField:"time",yField:"value",color:"#f8ca45",lineSize:2}]}}])})).then((function(t){e.setState({data:t})}))}}]),a}(n.a.Component),Ie="Ribavirin is gonadotoxic and teratogenic in multiple species.",Be=function(e){Object(A.a)(a,e);var t=Object(u.a)(a);function a(e){var i;return Object(c.a)(this,a),(i=t.call(this,e)).state={words:Ie.split(" "),selected:Array(Ie.split(" ").length).fill(!1)},i}return Object(d.a)(a,[{key:"selectedWord",value:function(e){var t=this.state.selected;t[e]=!this.state.selected[e],this.setState({selected:t})}},{key:"render",value:function(){return n.a.createElement(O,null,n.a.createElement(Oe,null))}}]),a}(n.a.Component);a(781),a(782),a(783),a(309),a(784),a(786);var Me=function(){return n.a.createElement(s.a,null,n.a.createElement(l.c,null,n.a.createElement(l.a,{path:"/lang/:lang",component:je}),n.a.createElement(l.a,{exact:!0,path:"/",component:je}),n.a.createElement(l.a,{exact:!0,path:"/cs",component:Be})))};Boolean("localhost"===window.location.hostname||"[::1]"===window.location.hostname||window.location.hostname.match(/^127(?:\.(?:25[0-5]|2[0-4][0-9]|[01]?[0-9][0-9]?)){3}$/));o.a.render(n.a.createElement(n.a.StrictMode,null,n.a.createElement(Me,null)),document.getElementById("root")),"serviceWorker"in navigator&&navigator.serviceWorker.ready.then((function(e){e.unregister()})).catch((function(e){console.error(e.message)}))}},[[353,1,2]]]);
//# sourceMappingURL=main.3f527b46.chunk.js.map